GENE_SYMBOL,GENE ID (HGNC),DISEASE_LABEL,DISEASE ID (MONDO),MOI,SOP,CLASSIFICATION,ONLINE REPORT,CLASSIFICATION DATE,GCEP
ANG,HGNC:483,amyotrophic lateral sclerosis type 9,MONDO:0012753,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ee17299-56dd-40a7-8cec-9a316f3e46f2-2022-02-08T000000.000Z,2022-02-08T00:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4dca2f56-87c6-4ac7-97bf-0889883b8e63-2021-11-12T215939.032Z,2021-11-12T21:59:39.032Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afd5a267-72c8-4a04-8404-4c819efe61c5-2021-09-21T030209.665Z,2021-09-21T03:02:09.665Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
CCNF,HGNC:1591,frontotemporal dementia and/or amyotrophic lateral sclerosis 5,MONDO:0030875,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7d6c258c-ce66-459a-a4ae-7376fcefde0d-2022-04-05T230455.308Z,2022-04-05T23:04:55.308Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
CHCHD10,HGNC:15559,frontotemporal dementia and/or amyotrophic lateral sclerosis 2,MONDO:0014395,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d154f67a-25ce-40d3-9de3-1f001753843a-2022-09-13T160000.000Z,2022-09-13T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
CHMP2B,HGNC:24537,frontotemporal dementia and/or amyotrophic lateral sclerosis 7,MONDO:0010936,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_287cab44-b8b6-411c-903a-6214ac5e98af-2022-07-12T160000.000Z,2022-07-12T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
DAO,HGNC:2671,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35ac00ac-3279-4c7e-89b6-8a75e3cae414-2022-04-12T103808.867Z,2022-04-12T10:38:08.867Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
DNAJC7,HGNC:12392,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2a12a19-b37a-4654-87fa-3a921c202c87-2022-10-27T160000.000Z,2022-10-27T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
ERBB4,HGNC:3432,amyotrophic lateral sclerosis type 19,MONDO:0014223,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fdd26ab6-0c1f-4322-9f70-cad651bb789f-2021-09-30T143144.993Z,2021-09-30T14:31:44.993Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
ERLIN1,HGNC:16947,amyotrophic lateral sclerosis,MONDO:0004976,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d668c62f-b002-4015-a629-ecbebed40e59-2021-07-27T160919.089Z,2021-07-27T16:09:19.089Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
FIG4,HGNC:16873,amyotrophic lateral sclerosis type 11,MONDO:0012945,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d038fb84-1f98-4047-b6c5-039a53756775-2022-08-09T160000.000Z,2022-08-09T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
FUS,HGNC:4010,amyotrophic lateral sclerosis type 6,MONDO:0011951,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2e8f55b-371e-438f-8923-73ca9b7ec034-2021-10-12T183601.087Z,2021-10-12T18:36:01.087Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
GLT8D1,HGNC:24870,familial amyotrophic lateral sclerosis,MONDO:0005144,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2c4f919-ccb5-4d9f-a604-5ed19e19057e-2022-11-08T170000.000Z,2022-11-08T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
HNRNPA2B1,HGNC:5033,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ffe711b-1ff6-4b11-b329-c0f820904764-2021-12-15T185159.600Z,2021-12-15T18:51:59.600Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
KIF5A,HGNC:6323,"amyotrophic lateral sclerosis, susceptibility to, 25",MONDO:0060670,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e7d2674-bce3-469c-b1e4-5cf57f5780a8-2022-05-26T110000.000Z,2022-05-26T11:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
MATR3,HGNC:6912,amyotrophic lateral sclerosis type 21,MONDO:0011632,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_97ed1e35-c1b2-40c7-a60e-54b3c24004c4-2021-09-23T160000.000Z,2021-09-23T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
NEK1,HGNC:7744,"amyotrophic lateral sclerosis, susceptibility to, 24",MONDO:0054750,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb4f311c-df33-4d9e-8ac6-731b43b93615-2022-04-29T192526.542Z,2022-04-29T19:25:26.542Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
OPTN,HGNC:17142,amyotrophic lateral sclerosis type 12,MONDO:0013264,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d8edc80-413c-4c76-bf06-89198175ac65-2022-05-10T170000.000Z,2022-05-10T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
PFN1,HGNC:8881,amyotrophic lateral sclerosis type 18,MONDO:0013891,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_948de40f-2cef-4235-ae87-491c01ffe803-2021-04-22T160000.000Z,2021-04-22T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
PRPH,HGNC:9461,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d11b04d-508a-4f91-9d9a-b5016fd0b940-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
SOD1,HGNC:11179,amyotrophic lateral sclerosis type 1,MONDO:0007103,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_97d17778-d21e-441f-b4b7-49eccaa8cbab-2021-07-13T192226.690Z,2021-07-13T19:22:26.690Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
SQSTM1,HGNC:11280,frontotemporal dementia and/or amyotrophic lateral sclerosis 3,MONDO:0014640,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dae3327f-6381-44cc-8baa-8fa1fc0d31d5-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TAF15,HGNC:11547,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_605446ae-fd1f-4451-bd49-643c24cd652e-2021-11-03T020945.214Z,2021-11-03T02:09:45.214Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TARDBP,HGNC:11571,amyotrophic lateral sclerosis type 10,MONDO:0012790,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf8bf781-25c9-4f16-b8cc-b0533390e4e2-2021-07-27T160623.437Z,2021-07-27T16:06:23.437Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TBK1,HGNC:11584,frontotemporal dementia and/or amyotrophic lateral sclerosis 4,MONDO:0014641,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_509b9e29-d354-4974-96e9-e819c3fee579-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TIA1,HGNC:11802,amyotrophic lateral sclerosis 26 with or without frontotemporal dementia,MONDO:0030885,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_555a0c95-2fb8-44d2-b2bf-c02b16d3fa6f-2022-10-11T170000.000Z,2022-10-11T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TUBA4A,HGNC:12407,amyotrophic lateral sclerosis type 22,MONDO:0014531,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7349d6e4-f351-4a8a-80f6-af62d3e716e5-2021-09-14T191334.954Z,2021-09-14T19:13:34.954Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
UBQLN2,HGNC:12509,amyotrophic lateral sclerosis type 15,MONDO:0010459,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17c06f6e-6fe1-4a61-bc35-026416e31dbb-2021-04-13T194634.543Z,2021-04-13T19:46:34.543Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
VAPB,HGNC:12649,amyotrophic lateral sclerosis type 8,MONDO:0012077,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da78d57d-1525-47b3-a649-743186d28eff-2021-12-15T183034.352Z,2021-12-15T18:30:34.352Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
VCP,HGNC:12666,inclusion body myopathy with Paget disease of bone and frontotemporal dementia,MONDO:0000507,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ea2bc4d-3b58-4b59-a5bc-9d8a96c452cb-2021-12-23T223510.433Z,2021-12-23T22:35:10.433Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
ACTB,HGNC:132,Baraitser-Winter cerebrofrontofacial syndrome,MONDO:0017579,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa13dfad-ab93-4521-874a-5ede8f608fe4-2021-10-26T165835.977Z,2021-10-26T16:58:35.977Z,Brain Malformations
AHI1,HGNC:21575,Joubert syndrome 3,MONDO:0012078,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0d8d22f-cea6-4f4f-bc71-e85303dccac1-2021-10-26T143345.589Z,2021-10-26T14:33:45.589Z,Brain Malformations
AKT3,HGNC:393,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52b1df18-387f-4c38-a655-682e4d2eb378-2021-07-29T213439.431Z,2021-07-29T21:34:39.431Z,Brain Malformations
AKT3,HGNC:393,microcephaly,MONDO:0001149,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e3b524c-5d27-43d6-a0db-4f8f7cf1f872-2021-10-26T150030.155Z,2021-10-26T15:00:30.155Z,Brain Malformations
CDK5RAP2,HGNC:18672,autosomal recessive primary microcephaly,MONDO:0016660,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70dace84-4d61-44f5-9de5-a81b5c70cad4-2022-01-25T170000.000Z,2022-01-25T17:00:00.000Z,Brain Malformations
DCC,HGNC:2701,mirror movements 1 and/or agenesis of the corpus callosum,MONDO:0100515,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f923f025-a973-4af8-b2c2-00dc39ed3026-2022-07-26T160000.000Z,2022-07-26T16:00:00.000Z,Brain Malformations
DCX,HGNC:2714,lissencephaly spectrum disorders,MONDO:0018838,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b0d23d1-5ca6-4584-9d74-cf78ca21b0e1-2021-02-23T150911.296Z,2021-02-23T15:09:11.296Z,Brain Malformations
DISP1,HGNC:19711,holoprosencephaly,MONDO:0016296,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef9d5a3b-d4ec-473b-b5a2-aaa25cf9babd-2022-09-27T090000.000Z,2022-09-27T09:00:00.000Z,Brain Malformations
DOCK6,HGNC:19189,Adams-Oliver syndrome,MONDO:0007034,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea64d74c-583d-4ed1-af91-6a7c6f80a1d3-2022-06-28T160000.000Z,2022-06-28T16:00:00.000Z,Brain Malformations
KIF21A,HGNC:19349,congenital fibrosis of extraocular muscles,MONDO:0007614,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc32bbc2-de76-42d0-8a6b-b3c3393ddd30-2021-10-26T144854.679Z,2021-10-26T14:48:54.679Z,Brain Malformations
KIF5C,HGNC:6325,complex cortical dysplasia with other brain malformations 2,MONDO:0014116,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c22eb3e1-4a72-480f-a360-20788fe1d9cd-2022-01-25T170000.000Z,2022-01-25T17:00:00.000Z,Brain Malformations
MTOR,HGNC:3942,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92ce0145-031d-41c4-8b74-0f9411629b64-2021-07-29T213256.506Z,2021-07-29T21:32:56.506Z,Brain Malformations
NEDD4L,HGNC:7728,periventricular nodular heterotopia 7,MONDO:0014966,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b131d46a-069b-4c2e-a290-e7df2519a2df-2021-11-30T170000.000Z,2021-11-30T17:00:00.000Z,Brain Malformations
PIK3CA,HGNC:8975,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c670e6ce-97b6-4383-bea6-5c216ab2a4a0-2021-07-29T213157.366Z,2021-07-29T21:31:57.366Z,Brain Malformations
PIK3R2,HGNC:8980,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc9a451e-0e75-47d2-a090-a2409732c465-2021-07-29T213616.452Z,2021-07-29T21:36:16.452Z,Brain Malformations
PROK2,HGNC:18455,hypogonadotropic hypogonadism 4 with or without anosmia,MONDO:0012528,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2305ec95-325d-4ebe-9401-121705e49660-2022-03-22T160000.000Z,2022-03-22T16:00:00.000Z,Brain Malformations
PROKR2,HGNC:15836,hypogonadotropic hypogonadism 3 with or without anosmia,MONDO:0009482,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ed279e5-f1a6-4f02-818e-e34aaf8c9947-2022-04-26T160000.000Z,2022-04-26T16:00:00.000Z,Brain Malformations
QARS1,HGNC:9751,diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome,MONDO:0014335,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b0cbc0e-c97c-4f6d-a351-0ac23a4ba8a5-2020-05-26T150033.131Z,2020-05-26T15:00:33.131Z,Brain Malformations
RAB3GAP1,HGNC:17063,Warburg micro syndrome,MONDO:0016649,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1e4a47e-757a-442f-b82f-2ddfd69d0854-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Brain Malformations
ROBO3,HGNC:13433,"gaze palsy, familial horizontal, with progressive scoliosis 1",MONDO:0020790,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_257a59f3-1f00-4bd8-b255-793bc692bc9c-2022-07-12T170000.000Z,2022-07-12T17:00:00.000Z,Brain Malformations
TUBB2B,HGNC:30829,complex cortical dysplasia with other brain malformations,MONDO:0000904,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81ced164-4ef1-4256-a727-84e79930efcc-2020-04-26T040000.000Z,2020-04-26T04:00:00.000Z,Brain Malformations
TUBG1,HGNC:12417,lissencephaly spectrum disorders,MONDO:0018838,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f773acb3-c59f-4c34-90f7-b5396b2dbfac-2022-04-26T160000.000Z,2022-04-26T16:00:00.000Z,Brain Malformations
WDR62,HGNC:24502,"microcephaly 2, primary, autosomal recessive, with or without cortical malformations",MONDO:0011435,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdbcb9de-2ded-46a0-a6d0-16b34ea22008-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Brain Malformations
ADD3,HGNC:245,complex neurodevelopmental disorder with motor features,MONDO:0100516,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a858435-3e50-406f-8ec3-9f4e40b1c392-2022-08-15T180000.000Z,2022-08-15T18:00:00.000Z,Cerebral Palsy
AP5Z1,HGNC:22197,hereditary spastic paraplegia,MONDO:0019064,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_020a234e-180c-4d9f-8f04-bd79eac6046e-2022-09-19T160000.000Z,2022-09-19T16:00:00.000Z,Cerebral Palsy
DDHD1,HGNC:19714,hereditary spastic paraplegia,MONDO:0019064,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ba9bbb1-e36f-41db-9e56-23496613e46d-2022-12-01T200000.000Z,2022-12-01T20:00:00.000Z,Cerebral Palsy
EMC1,HGNC:28957,complex neurodevelopmental disorder with motor features,MONDO:0100516,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_659c7312-5d0a-44d0-9bd0-3e2b2ba385ce-2022-11-03T013000.000Z,2022-11-03T01:30:00.000Z,Cerebral Palsy
EMC1,HGNC:28957,complex neurodevelopmental disorder with motor features,MONDO:0100516,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab319081-d3bf-436a-af1e-fce77cf8837a-2022-10-06T013000.000Z,2022-10-06T01:30:00.000Z,Cerebral Palsy
FITM2,HGNC:16135,Siddiqi syndrome,MONDO:0032842,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a18aeda-fbe1-49b3-9542-6402ea61b4c0-2022-10-17T160000.000Z,2022-10-17T16:00:00.000Z,Cerebral Palsy
ARHGEF10,HGNC:14103,autosomal dominant slowed nerve conduction velocity,MONDO:0011998,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b23121f9-57e1-48ac-a2bc-d5a293829530-2020-10-05T160423.090Z,2020-10-05T16:04:23.090Z,Charcot-Marie-Tooth
ATL1,HGNC:11231,"neuropathy, hereditary sensory, type 1D",MONDO:0013381,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c0282d1-5ab4-4a86-b1f6-165a3dbd515a-2022-02-10T020857.711Z,2022-02-10T02:08:57.711Z,Charcot-Marie-Tooth
ATL3,HGNC:24526,"neuropathy, hereditary sensory, type 1F",MONDO:0014286,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_132d0be7-2003-43ed-a934-1cf60cf45773-2021-07-13T160000.000Z,2021-07-13T16:00:00.000Z,Charcot-Marie-Tooth
ATP1A1,HGNC:799,"charcot-marie-tooth disease, axonal, type 2DD",MONDO:0054833,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65182954-6603-4880-85fa-352700bd784b-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth
ATP7A,HGNC:869,X-linked distal spinal muscular atrophy type 3,MONDO:0010338,XL,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec7c42f3-3cad-4020-aa75-cf103c5381ba-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02472719-c26d-40ff-8ad4-897ef7a6800a-2022-09-23T160000.000Z,2022-09-23T16:00:00.000Z,Charcot-Marie-Tooth
DNAJB2,HGNC:5228,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d726e4f-6edb-4d04-b2ae-2cd05ecdd8db-2022-02-10T022350.942Z,2022-02-10T02:23:50.942Z,Charcot-Marie-Tooth
DNM2,HGNC:2974,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7bc54e5d-eed5-4d40-9e0d-143bfeb88cac-2020-10-27T131827.010Z,2020-10-27T13:18:27.010Z,Charcot-Marie-Tooth
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d90c7de8-a72a-4c54-bab8-fe9d4aef0409-2021-12-14T170000.000Z,2021-12-14T17:00:00.000Z,Charcot-Marie-Tooth
EGR2,HGNC:3239,Charcot-Marie-Tooth disease,MONDO:0015626,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6e83e27-0c9a-4475-92f5-745303931858-2021-11-17T033516.468Z,2021-11-17T03:35:16.468Z,Charcot-Marie-Tooth
FBXO38,HGNC:28844,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_350c1f45-5afd-4f36-8973-94acaf7bb961-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
FGD4,HGNC:19125,Charcot-Marie-Tooth disease,MONDO:0015626,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0aae8cd-9d57-4d8c-83ae-ed968cf186bc-2020-04-14T131822.010Z,2020-04-14T13:18:22.010Z,Charcot-Marie-Tooth
FIG4,HGNC:16873,Charcot-Marie-Tooth disease,MONDO:0015626,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cbc44812-5fe4-4e11-ac89-58e4175d4463-2021-09-23T003544.594Z,2021-09-23T00:35:44.594Z,Charcot-Marie-Tooth
GAN,HGNC:4137,giant axonal neuropathy 1,MONDO:0009749,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9f65afa-5cb1-457e-abff-ab110145a32d-2022-02-10T021239.651Z,2022-02-10T02:12:39.651Z,Charcot-Marie-Tooth
GARS1,HGNC:4162,Charcot-Marie-Tooth disease type 2D,MONDO:0011091,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_168242d1-ef2e-486a-a45a-ed96187bd4d2-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
GDAP1,HGNC:15968,Charcot-Marie-Tooth disease,MONDO:0015626,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6d93637-02f5-4f5d-b7a9-17356f084149-2020-07-28T144211.873Z,2020-07-28T14:42:11.873Z,Charcot-Marie-Tooth
GJB1,HGNC:4283,Charcot-Marie-Tooth disease X-linked dominant 1,MONDO:0010549,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcacd858-2376-4cc0-983a-156145e36595-2020-01-14T170000.000Z,2020-01-14T17:00:00.000Z,Charcot-Marie-Tooth
GNB4,HGNC:20731,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8cecdd7-06d8-4697-8cd9-32900c366371-2020-04-14T132010.930Z,2020-04-14T13:20:10.930Z,Charcot-Marie-Tooth
HINT1,HGNC:4912,Charcot-Marie-Tooth disease,MONDO:0015626,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_170aae71-9b16-49b1-be29-44f98db2f72e-2021-03-22T201109.360Z,2021-03-22T20:11:09.360Z,Charcot-Marie-Tooth
HSPB1,HGNC:5246,Charcot-Marie-Tooth disease axonal type 2F,MONDO:0011687,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bec365e-7832-41f1-89cc-48b8ab570c76-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Charcot-Marie-Tooth
HSPB8,HGNC:30171,autosomal dominant distal hereditary motor neuropathy,MONDO:0015362,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_044a2465-8e0a-44ff-8d00-1ec3a76183c8-2021-03-22T201855.441Z,2021-03-22T20:18:55.441Z,Charcot-Marie-Tooth
INF2,HGNC:23791,Charcot-Marie-Tooth disease dominant intermediate E,MONDO:0013758,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5215f2cf-99c9-405a-b221-18f412abd1f0-2021-03-22T202012.410Z,2021-03-22T20:20:12.410Z,Charcot-Marie-Tooth
KIF1B,HGNC:16636,Charcot-Marie-Tooth disease type 2A1,MONDO:0007308,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae6ffeae-9609-47bf-89a9-4863cf6ef05c-2020-10-05T161930.420Z,2020-10-05T16:19:30.420Z,Charcot-Marie-Tooth
LITAF,HGNC:16841,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7106097-314c-487a-9770-b7dea3f25f37-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Charcot-Marie-Tooth
MARS1,HGNC:6898,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f042c42-893b-4c98-a719-0f778a54be43-2020-10-05T160651.479Z,2020-10-05T16:06:51.479Z,Charcot-Marie-Tooth
MED25,HGNC:28845,Charcot-Marie-Tooth disease type 2B2,MONDO:0011570,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0e0d66f-c68d-4df3-bab2-71afc448e4b0-2021-03-22T201527.084Z,2021-03-22T20:15:27.084Z,Charcot-Marie-Tooth
MFN2,HGNC:16877,axonal hereditary motor and sensory neuropathy,MONDO:0018775,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a04350b3-5fe9-438a-9e90-db0055ed15e7-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth
MME,HGNC:7154,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d426d95-70b5-4537-809f-9f2520fc39e9-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Charcot-Marie-Tooth
MPZ,HGNC:7225,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_11f638d2-d8d2-4fe4-ab79-acff5cf32a18-2020-08-25T160000.000Z,2020-08-25T16:00:00.000Z,Charcot-Marie-Tooth
MTMR2,HGNC:7450,demyelinating hereditary motor and sensory neuropathy,MONDO:0018776,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44a837e2-ae06-4e4d-b7cf-ae2a3009b47d-2020-02-11T170000.000Z,2020-02-11T17:00:00.000Z,Charcot-Marie-Tooth
NEFH,HGNC:7737,Charcot-Marie-Tooth disease axonal type 2CC,MONDO:0014836,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e1390ea-fd6c-4fa4-9b43-0eccff9e2829-2020-10-05T161645.817Z,2020-10-05T16:16:45.817Z,Charcot-Marie-Tooth
NEFL,HGNC:7739,Charcot-Marie-Tooth disease type 2,MONDO:0018993,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49d4cf82-b365-456e-9e35-2b28a66b71ec-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
NEFL,HGNC:7739,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_57ec533a-b1cb-4d1d-b12a-61ee6ac6ab07-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
NTRK1,HGNC:8031,hereditary sensory and autonomic neuropathy type 4,MONDO:0009746,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e716345f-08da-4a06-b3e1-d07974a4305d-2021-11-17T030955.951Z,2021-11-17T03:09:55.951Z,Charcot-Marie-Tooth
PMP2,HGNC:9117,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa4c5730-f807-45d7-afe7-573a3960916f-2021-03-22T201734.319Z,2021-03-22T20:17:34.319Z,Charcot-Marie-Tooth
PMP22,HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_169edbc0-b942-43f1-885d-8d47ccdb6d90-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth
PRX,HGNC:13797,Charcot-Marie-Tooth disease type 4,MONDO:0018995,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_471d2fcc-f9d4-49d7-92b9-d16f5f751d83-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
RAB7A,HGNC:9788,Charcot-Marie-Tooth disease type 2,MONDO:0018993,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_222dbfa6-db75-42a0-bab6-338b46a316c3-2022-02-10T021034.172Z,2022-02-10T02:10:34.172Z,Charcot-Marie-Tooth
SBF1,HGNC:10542,Charcot-Marie-Tooth disease type 4B3,MONDO:0014117,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0f814d9-02db-4c0c-8e1c-20a7759d993f-2021-11-20T022238.296Z,2021-11-20T02:22:38.296Z,Charcot-Marie-Tooth
SBF2,HGNC:2135,Charcot-Marie-Tooth disease type 4B2,MONDO:0011475,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01893bf4-e95d-4206-9d2e-e3822f778b7a-2021-03-22T201309.257Z,2021-03-22T20:13:09.257Z,Charcot-Marie-Tooth
SCN11A,HGNC:10583,autosomal dominant hereditary sensory and autonomic neuropathy,MONDO:0015365,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_abe8c0db-503c-46fa-a2a6-e4d6071219d0-2022-02-25T020007.355Z,2022-02-25T02:00:07.355Z,Charcot-Marie-Tooth
SETX,HGNC:445,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f355b8f-1cd9-401c-8f34-b9b3e2fe939b-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Charcot-Marie-Tooth
SH3TC2,HGNC:29427,autosomal recessive hereditary demyelinating motor and sensory neuropathy,MONDO:0015361,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d2b214f-3086-4012-bf4b-a6e651618f0b-2022-02-10T020711.223Z,2022-02-10T02:07:11.223Z,Charcot-Marie-Tooth
SLC25A46,HGNC:25198,"neuropathy, hereditary motor and sensory, type 6B",MONDO:0014671,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9852fb40-0df1-4668-ba57-38a4971cb244-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Charcot-Marie-Tooth
SLC5A7,HGNC:14025,"neuronopathy, distal hereditary motor, type 7A",MONDO:0008024,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6e46608-98f5-4e4d-9bcf-22e42997af6e-2021-11-20T022003.630Z,2021-11-20T02:20:03.630Z,Charcot-Marie-Tooth
SPTLC2,HGNC:11278,"neuropathy, hereditary sensory and autonomic, type 1C",MONDO:0013337,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2294e1cf-3aad-471e-a360-9f6f8c3b4d8f-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
TRPV4,HGNC:18083,neuromuscular disease,MONDO:0019056,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b89b03c3-24c7-4424-989c-abd65eb2b7ec-2021-12-14T145310.482Z,2021-12-14T14:53:10.482Z,Charcot-Marie-Tooth
WARS1,HGNC:12729,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93643521-0988-4c4b-b458-988044cfad6f-2022-02-10T020458.490Z,2022-02-10T02:04:58.490Z,Charcot-Marie-Tooth
YARS1,HGNC:12840,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c326f90-be08-4bb3-9593-b2df48f29ca1-2020-04-28T160000.000Z,2020-04-28T16:00:00.000Z,Charcot-Marie-Tooth
ALX1,HGNC:1494,frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome,MONDO:0013271,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ade0e1d8-3f68-4276-bc1d-173ca2d4936f-2022-10-13T160000.000Z,2022-10-13T16:00:00.000Z,Craniofacial Malformations
EFNB1,HGNC:3226,craniofrontonasal syndrome,MONDO:0010570,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31ffbd0b-5c6b-4396-a84c-9330d81e4a08-2020-10-26T154650.453Z,2020-10-26T15:46:50.453Z,Craniofacial Malformations
ERF,HGNC:3444,craniosynostosis 4,MONDO:0010929,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1954ba97-532a-4ef3-9d62-c4ebfd252084-2021-06-12T062024.684Z,2021-06-12T06:20:24.684Z,Craniofacial Malformations
FGFR1,HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4fef65d0-f73c-45fe-968e-86073674cb7e-2021-05-21T224433.397Z,2021-05-21T22:44:33.397Z,Craniofacial Malformations
FGFR1,HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d958e743-2ca0-4bb9-a198-364dd58005c3-2021-03-22T203501.315Z,2021-03-22T20:35:01.315Z,Craniofacial Malformations
FGFR1,HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec5034c6-70cb-4ba3-bbb9-f65f6cad393d-2021-03-16T235509.401Z,2021-03-16T23:55:09.401Z,Craniofacial Malformations
FGFR2,HGNC:3689,apert syndrome,MONDO:0007041,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2aa63602-d820-4fee-893b-b807e7b62f28-2021-12-14T221137.192Z,2021-12-14T22:11:37.192Z,Craniofacial Malformations
FGFR2,HGNC:3689,Beare-Stevenson cutis gyrata syndrome,MONDO:0007412,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7805e806-44ee-4339-a078-d62c204bff00-2022-03-31T163711.748Z,2022-03-31T16:37:11.748Z,Craniofacial Malformations
FGFR2,HGNC:3689,Crouzon syndrome,MONDO:0007405,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2cfa70a-750f-4357-98b9-f5c30ca4dc26-2021-12-23T165345.170Z,2021-12-23T16:53:45.170Z,Craniofacial Malformations
FGFR2,HGNC:3689,Pfeiffer syndrome,MONDO:0007043,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eccfe56b-15d7-4ba9-abf2-163dfd3dab3c-2022-03-21T210958.425Z,2022-03-21T21:09:58.425Z,Craniofacial Malformations
FGFR3,HGNC:3690,Crouzon syndrome-acanthosis nigricans syndrome,MONDO:0012833,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_98727c21-26dd-4e65-b75e-8ec82d95ba97-2021-11-18T170000.000Z,2021-11-18T17:00:00.000Z,Craniofacial Malformations
FGFR3,HGNC:3690,Muenke syndrome,MONDO:0011274,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e94c1870-5413-4f75-8925-8bea54199d47-2022-03-29T172023.530Z,2022-03-29T17:20:23.530Z,Craniofacial Malformations
MEGF8,HGNC:3233,MEGF8-related Carpenter syndrome,MONDO:0013998,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd9400f1-2c0b-4ffd-989a-486b81779a53-2021-12-23T193047.075Z,2021-12-23T19:30:47.075Z,Craniofacial Malformations
MSX2,HGNC:7392,parietal foramina,MONDO:0018953,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2bb862dd-e6d2-4dc8-a7f3-3a03d58f9ade-2020-07-08T170000.000Z,2020-07-08T17:00:00.000Z,Craniofacial Malformations
MSX2,HGNC:7392,craniosynostosis 2,MONDO:0011481,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac8a9313-9ef2-4556-9a25-db7fa2ed99ed-2020-09-28T170000.000Z,2020-09-28T17:00:00.000Z,Craniofacial Malformations
POR,HGNC:9208,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,MONDO:0008726,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6275d46a-f005-45f8-b3ec-e9722f8dd39e-2022-03-23T193729.312Z,2022-03-23T19:37:29.312Z,Craniofacial Malformations
RAB23,HGNC:14263,RAB23-related Carpenter syndrome,MONDO:0008710,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_46756b21-4bb5-4384-a42c-cf10c76e98c8-2021-04-22T160000.000Z,2021-04-22T16:00:00.000Z,Craniofacial Malformations
SKI,HGNC:10896,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_019ffb7a-be5f-482d-9adf-e28d5aadaede-2020-10-29T160000.000Z,2020-10-29T16:00:00.000Z,Craniofacial Malformations
TCF12,HGNC:11623,TCF12-related craniosynostosis,MONDO:0014128,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_11e46ed0-dbfb-4151-ba1c-cc56214d6ca6-2021-01-28T170000.000Z,2021-01-28T17:00:00.000Z,Craniofacial Malformations
TWIST1,HGNC:12428,Sweeney-Cox syndrome,MONDO:0060592,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14ba10ad-ebb5-491f-b4d6-639890ab7ab9-2021-03-26T213222.762Z,2021-03-26T21:32:22.762Z,Craniofacial Malformations
TWIST1,HGNC:12428,Saethre-Chotzen syndrome,MONDO:0007042,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1730a1bb-49c2-4c11-8c45-e8747d8fb91d-2021-01-28T180000.000Z,2021-01-28T18:00:00.000Z,Craniofacial Malformations
TWIST1,HGNC:12428,TWIST1-related craniosynostosis,MONDO:0007399,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bda425f8-b760-4484-9336-b3e572d402ab-2021-06-10T160000.000Z,2021-06-10T16:00:00.000Z,Craniofacial Malformations
AARS1,HGNC:20,undetermined early-onset epileptic encephalopathy,MONDO:0018614,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac62fe65-ee56-4146-9fe4-00dc1db2d958-2018-11-20T170000.000Z,2018-11-20T17:00:00.000Z,Epilepsy
ABAT,HGNC:23,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a5138ad-d4b8-4ea1-aa78-b5d1f07b2b82-2022-04-19T160000.000Z,2022-04-19T16:00:00.000Z,Epilepsy
ALG13,HGNC:30881,developmental and epileptic encephalopathy,MONDO:0100062,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f14dd634-ec5c-48cc-a375-e3cfd0c6e832-2018-04-19T160000.000Z,2018-04-19T16:00:00.000Z,Epilepsy
ARX,HGNC:18060,developmental and epileptic encephalopathy,MONDO:0100062,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a5357ce-2161-4a7f-a8e1-a1dba4550e57-2019-06-04T160000.000Z,2019-06-04T16:00:00.000Z,Epilepsy
ATP1A2,HGNC:800,familial or sporadic hemiplegic migraine,MONDO:0018925,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fe788a45-b8da-4377-acdb-5dd55fcc3130-2021-03-02T183446.232Z,2021-03-02T18:34:46.232Z,Epilepsy
BRAT1,HGNC:21701,neonatal-onset encephalopathy with rigidity and seizures,MONDO:0013784,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_698a4cb3-df52-432b-9d3e-d3d76111db25-2022-09-13T170000.000Z,2022-09-13T17:00:00.000Z,Epilepsy
BRAT1,HGNC:21701,neurodevelopmental disorder with cerebellar atrophy and with or without seizures,MONDO:0020841,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93a7b6f1-75e5-4f97-be9d-62fb5770b8cb-2022-09-06T170000.000Z,2022-09-06T17:00:00.000Z,Epilepsy
CACNA1H,HGNC:1395,epilepsy,MONDO:0005027,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c3208279-a38d-4b38-b4f9-3af2610c4936-2018-07-30T040000.000Z,2018-07-30T04:00:00.000Z,Epilepsy
CACNB4,HGNC:1404,epilepsy,MONDO:0005027,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2fad131-8e91-4874-9394-8b86d6d62abb-2022-07-05T160000.000Z,2022-07-05T16:00:00.000Z,Epilepsy
CASR,HGNC:1514,epilepsy,MONDO:0005027,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ddebf083-3434-4401-9b6b-9ec24aceec89-2021-03-03T123827.967Z,2021-03-03T12:38:27.967Z,Epilepsy
CHD2,HGNC:1917,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5af80ea6-31c6-47d2-a5a5-299380f5593c-2018-07-18T160000.000Z,2018-07-18T16:00:00.000Z,Epilepsy
CHRNA2,HGNC:1956,sleep-related hypermotor epilepsy,MONDO:0000030,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f832b8a-af5a-494e-bfdb-70cc619addf1-2020-12-25T015652.186Z,2020-12-25T01:56:52.186Z,Epilepsy
CHRNA2,HGNC:1956,benign familial infantile epilepsy,MONDO:0017615,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7916abab-d963-4e9c-8913-1decc21b680c-2020-01-07T050000.000Z,2020-01-07T05:00:00.000Z,Epilepsy
CHRNA4,HGNC:1958,sleep-related hypermotor epilepsy,MONDO:0000030,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3aa0108-5514-48ba-a09c-5506b2030d1f-2020-02-18T170000.000Z,2020-02-18T17:00:00.000Z,Epilepsy
CLN5,HGNC:2076,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a522b1d6-5ade-4749-94b8-d5426bbe5961-2021-09-08T023930.981Z,2021-09-08T02:39:30.981Z,Epilepsy
CLN6,HGNC:2077,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09654b45-6649-4d11-b43e-aeb6d20fb86d-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Epilepsy
CLN8,HGNC:2079,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_68775ed0-576e-4ee7-90f2-d16329ecd7c1-2020-09-07T220116.243Z,2020-09-07T22:01:16.243Z,Epilepsy
CNTNAP2,HGNC:13830,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3af732e2-062d-4bb3-a3cd-2045e460dc8f-2021-06-15T160000.000Z,2021-06-15T16:00:00.000Z,Epilepsy
CPA6,HGNC:17245,epilepsy,MONDO:0005027,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1cb32379-82a8-425d-ac80-3d740e1cc10b-2021-07-29T132527.108Z,2021-07-29T13:25:27.108Z,Epilepsy
CPA6,HGNC:17245,epilepsy,MONDO:0005027,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7b3ebd58-dccb-4c73-b5e4-1ec55171f2fe-2021-07-29T135909.720Z,2021-07-29T13:59:09.720Z,Epilepsy
CRH,HGNC:2355,epilepsy,MONDO:0005027,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1719f97-0d6c-4ed3-93bc-13cc8e1f1d6e-2021-09-21T160000.000Z,2021-09-21T16:00:00.000Z,Epilepsy
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2926506c-5b75-4340-b821-e3ac846b6621-2020-06-16T160000.000Z,2020-06-16T16:00:00.000Z,Epilepsy
CSTB,HGNC:2482,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_accafcd4-ba3c-4049-9285-1de877d256ec-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Epilepsy
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba-2020-11-03T180000.000Z,2020-11-03T18:00:00.000Z,Epilepsy
CTSF,HGNC:2531,adult neuronal ceroid lipofuscinosis,MONDO:0019260,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9079835-78f4-4759-a43a-9786270dc02e-2022-04-21T142141.505Z,2022-04-21T14:21:41.505Z,Epilepsy
DEPDC5,HGNC:18423,focal epilepsy,MONDO:0005384,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82a82c75-f9a5-4f51-a15c-6513c13df57c-2018-08-07T040000.000Z,2018-08-07T04:00:00.000Z,Epilepsy
DNAJC5,HGNC:16235,adult neuronal ceroid lipofuscinosis,MONDO:0019260,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67f55ef1-b312-4aac-bc04-67beb2405b4f-2021-07-30T052005.845Z,2021-07-30T05:20:05.845Z,Epilepsy
DNM1,HGNC:2972,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31f598a3-7efd-4e43-83f3-587e98924260-2016-12-13T170000.000Z,2016-12-13T17:00:00.000Z,Epilepsy
DOCK7,HGNC:19190,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b6ed421-950b-4862-bade-dc545555ac29-2021-07-28T192512.688Z,2021-07-28T19:25:12.688Z,Epilepsy
EEF1A2,HGNC:3192,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17551147-b62c-47a9-a12a-f425c23d90ff-2019-03-19T160000.000Z,2019-03-19T16:00:00.000Z,Epilepsy
EFHC1,HGNC:16406,epilepsy,MONDO:0005027,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2338bd8-c9ea-464b-8281-84472771a657-2018-07-27T160000.000Z,2018-07-27T16:00:00.000Z,Epilepsy
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f970ced6-0164-41ed-9e1f-1fb9f892bca6-2020-05-23T190000.000Z,2020-05-23T19:00:00.000Z,Epilepsy
GABRA1,HGNC:4075,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60478d36-384e-4246-ba8a-730755d6f216-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Epilepsy
GABRB3,HGNC:4083,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9327dac-6f76-4881-8a23-ef2b210f92e7-2019-02-05T170000.000Z,2019-02-05T17:00:00.000Z,Epilepsy
GABRG2,HGNC:4087,epilepsy,MONDO:0005027,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a3176e9-ac0c-41fe-ae40-0750726c33d8-2020-01-21T170000.000Z,2020-01-21T17:00:00.000Z,Epilepsy
GNAO1,HGNC:4389,movement disorder,MONDO:0005395,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_418a5a18-3d0e-4cef-84b4-74c5accc0df1-2019-02-19T170000.000Z,2019-02-19T17:00:00.000Z,Epilepsy
GNAO1,HGNC:4389,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b56856e2-8e6f-4f01-a6bd-1642fee71e5b-2018-12-18T170000.000Z,2018-12-18T17:00:00.000Z,Epilepsy
GRIN1,HGNC:4584,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b98e5df5-8f39-4fd6-9715-bb8da7dc1806-2018-11-20T050000.000Z,2018-11-20T05:00:00.000Z,Epilepsy
GRIN2A,HGNC:4585,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c405372-b99b-42fc-836d-65d7c0cbd279-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Epilepsy
GRIN2B,HGNC:4586,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff8d9346-2ab7-4ef1-9071-9b8ae4178174-2019-03-19T170000.000Z,2019-03-19T17:00:00.000Z,Epilepsy
GRIN2D,HGNC:4588,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a52befb3-e9e0-46f1-9abf-8ead03151230-2022-03-15T190000.000Z,2022-03-15T19:00:00.000Z,Epilepsy
GRN,HGNC:4601,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49eb0915-acff-423d-a70f-d00d4319d404-2023-01-03T170000.000Z,2023-01-03T17:00:00.000Z,Epilepsy
KCNA2,HGNC:6220,undetermined early-onset epileptic encephalopathy,MONDO:0018614,AD,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10049,2017-10-20T00:00:00,Epilepsy
KCNA2,HGNC:6220,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a825f85-585a-4086-8118-ce912d4c1469-2022-05-18T130146.911Z,2022-05-18T13:01:46.911Z,Epilepsy
KCNB1,HGNC:6231,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_986348ad-e8bb-4391-9478-7834a19415cb-2019-04-16T160000.000Z,2019-04-16T16:00:00.000Z,Epilepsy
KCNC1,HGNC:6233,progressive myoclonus epilepsy,MONDO:0020074,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35d2beba-40f6-472d-842c-41925f486ba9-2022-11-07T200000.000Z,2022-11-07T20:00:00.000Z,Epilepsy
KCNC1,HGNC:6233,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5146494e-71e7-4e06-b10f-cc126429e3fb-2022-11-07T200000.000Z,2022-11-07T20:00:00.000Z,Epilepsy
KCNMA1,HGNC:6284,generalized epilepsy-paroxysmal dyskinesia syndrome,MONDO:0012276,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4bd10bb7-67d0-4c30-a944-9a46fd2f361a-2022-03-08T104405.484Z,2022-03-08T10:44:05.484Z,Epilepsy
KCNMA1,HGNC:6284,generalized epilepsy-paroxysmal dyskinesia syndrome,MONDO:0012276,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9aabc05e-8452-4b72-bd07-ae1a1fc40dfc-2022-03-08T114915.435Z,2022-03-08T11:49:15.435Z,Epilepsy
KCTD7,HGNC:21957,progressive myoclonus epilepsy,MONDO:0020074,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e6068b08-413e-4105-b8dc-97426d64c6c4-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Epilepsy
LGI1,HGNC:6572,Autosomal dominant epilepsy with auditory features,MONDO:0010898,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_662936d4-11a7-43f3-9daf-4ba1a7c92ffe-2020-07-07T183907.849Z,2020-07-07T18:39:07.849Z,Epilepsy
MAGI2,HGNC:18957,epilepsy,MONDO:0005027,XL,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7d622b88-9c77-47f8-93b1-808517da0cff-2018-06-19T160000.000Z,2018-06-19T16:00:00.000Z,Epilepsy
MFSD8,HGNC:28486,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f42cb66-5f28-4674-8f5a-76e15880bbfc-2020-12-15T170000.000Z,2020-12-15T17:00:00.000Z,Epilepsy
NECAP1,HGNC:24539,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b-2023-01-17T200000.000Z,2023-01-17T20:00:00.000Z,Epilepsy
NHLRC1,HGNC:21576,Lafora disease,MONDO:0009697,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c4dbe715-b897-482d-afeb-b05c0653a79a-2020-03-03T170000.000Z,2020-03-03T17:00:00.000Z,Epilepsy
NPRL3,HGNC:14124,focal epilepsy,MONDO:0005384,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_19a476ce-334f-4727-bbf2-ea4cfa37a223-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Epilepsy
PCDH19,HGNC:14270,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c00aad39-c6c4-4a46-af84-613592b166a3-2018-09-04T160000.000Z,2018-09-04T16:00:00.000Z,Epilepsy
PIGA,HGNC:8957,developmental and epileptic encephalopathy,MONDO:0100062,XL,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1fbb591b-eb34-4b73-a741-2f101886c896-2019-04-26T160000.000Z,2019-04-26T16:00:00.000Z,Epilepsy
PIGO,HGNC:23215,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_830b11ca-6ec1-4aa9-bb44-379f03f738c7-2021-10-21T004641.341Z,2021-10-21T00:46:41.341Z,Epilepsy
PLCB1,HGNC:15917,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7887c3b-332b-4586-93cf-4098796ab66f-2020-09-18T040000.000Z,2020-09-18T04:00:00.000Z,Epilepsy
PNKP,HGNC:9154,"microcephaly, seizures, and developmental delay",MONDO:0013254,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_901a984a-c678-4f35-81c2-9436785d3698-2020-04-17T165304.309Z,2020-04-17T16:53:04.309Z,Epilepsy
PNPO,HGNC:30260,pyridoxal phosphate-responsive seizures,MONDO:0012407,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3ff7b38-dd26-458a-afbb-4870785c42ec-2020-12-15T170000.000Z,2020-12-15T17:00:00.000Z,Epilepsy
PRICKLE1,HGNC:17019,epilepsy,MONDO:0005027,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71a3c632-fd63-4103-a069-5e9e413043e7-2020-09-01T160000.000Z,2020-09-01T16:00:00.000Z,Epilepsy
PRICKLE1,HGNC:17019,progressive myoclonus epilepsy,MONDO:0020074,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4e1195f-21ea-4721-b94b-99604e7c6554-2020-08-18T170000.000Z,2020-08-18T17:00:00.000Z,Epilepsy
PRICKLE2,HGNC:20340,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1713884-4e19-4810-b73f-871645cfc0c3-2022-12-29T170000.000Z,2022-12-29T17:00:00.000Z,Epilepsy
PRRT2,HGNC:30500,infantile convulsions and choreoathetosis,MONDO:0011178,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62af25b8-b9a4-421f-b897-4fc222569618-2020-01-21T213814.191Z,2020-01-21T21:38:14.191Z,Epilepsy
PURA,HGNC:9701,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6819633c-e488-4856-8dec-3981cd14db9b-2018-12-18T170000.000Z,2018-12-18T17:00:00.000Z,Epilepsy
ROGDI,HGNC:29478,amelocerebrohypohidrotic syndrome,MONDO:0009185,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc4132b5-fd80-440b-b7ae-65f4d28f33f1-2022-06-21T160000.000Z,2022-06-21T16:00:00.000Z,Epilepsy
RORB,HGNC:10259,epilepsy,MONDO:0005027,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_88c55f22-3f6f-467a-b38b-267f93d6cc9a-2022-09-21T190000.000Z,2022-09-21T19:00:00.000Z,Epilepsy
RYR3,HGNC:10485,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a277276e-7efa-45c9-ad01-74e9aa2dea63-2018-06-19T160000.000Z,2018-06-19T16:00:00.000Z,Epilepsy
SCARB2,HGNC:1665,progressive myoclonus epilepsy,MONDO:0020074,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc556613-cf24-44ee-8354-98ce91f78d7d-2020-08-23T190000.000Z,2020-08-23T19:00:00.000Z,Epilepsy
SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy
SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy
SCN1A,HGNC:10585,Dravet syndrome,MONDO:0100135,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60334a15-c73e-42ce-b7d2-4796c2affde4-2019-08-20T160000.000Z,2019-08-20T16:00:00.000Z,Epilepsy
SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy
SCN1B,HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Epilepsy
SCN1B,HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4c35c20-6e59-46cf-9347-852b80af8dcc-2022-01-04T211051.949Z,2022-01-04T21:10:51.949Z,Epilepsy
SCN2A,HGNC:10588,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a1b7361-5c9e-4803-844d-ad6606a0acdb-2019-05-07T160000.000Z,2019-05-07T16:00:00.000Z,Epilepsy
SCN3A,HGNC:10590,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9750183-c66c-4dd8-855e-9509fc9c25c6-2022-05-09T233102.697Z,2022-05-09T23:31:02.697Z,Epilepsy
SCN8A,HGNC:10596,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f52993aa-ddee-483d-b15e-dbf21608d5a9-2018-07-18T125000.560Z,2018-07-18T12:50:00.560Z,Epilepsy
SCN9A,HGNC:10597,epilepsy,MONDO:0005027,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72a91ef6-e052-44a4-b14e-6a5ba93393ff-2021-03-09T163649.218Z,2021-03-09T16:36:49.218Z,Epilepsy
SERPINI1,HGNC:8943,progressive myoclonus epilepsy,MONDO:0020074,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b31db78-6595-440d-a3f1-b3b5ca361611-2022-06-05T190000.000Z,2022-06-05T19:00:00.000Z,Epilepsy
SIK1,HGNC:11142,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd76888e-9502-48f3-af06-56f1ae5ed975-2018-10-02T160000.000Z,2018-10-02T16:00:00.000Z,Epilepsy
SLC25A22,HGNC:19954,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9a7ba06-6ddf-4a94-a0df-0b6c164f72b9-2020-05-19T160000.000Z,2020-05-19T16:00:00.000Z,Epilepsy
SLC35A2,HGNC:11022,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8173aea-692d-4f50-aca4-228e3df16e80-2021-04-23T160000.000Z,2021-04-23T16:00:00.000Z,Epilepsy
SPTAN1,HGNC:11273,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6737ac52-8177-4be1-95fe-92ddecbf5636-2019-01-17T170000.000Z,2019-01-17T17:00:00.000Z,Epilepsy
SRPX2,HGNC:30668,epilepsy,MONDO:0005027,XL,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9555886-a248-4bd4-b3dc-50ff503d6e7a-2018-07-19T160000.000Z,2018-07-19T16:00:00.000Z,Epilepsy
ST3GAL5,HGNC:10872,GM3 synthase deficiency,MONDO:0018274,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5ea65e3-6a02-4435-9ef5-100564d3497c-2022-04-05T160000.000Z,2022-04-05T16:00:00.000Z,Epilepsy
STXBP1,HGNC:11444,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8d21800-652f-431b-a5d8-4208d4e91d46-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Epilepsy
SYNGAP1,HGNC:11497,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b19f2a30-5538-4339-9018-150fd1bcd9c8-2019-04-02T160000.000Z,2019-04-02T16:00:00.000Z,Epilepsy
SYNJ1,HGNC:11503,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a283140a-5d8d-47bb-9dff-32d091a16c7c-2022-02-10T044803.180Z,2022-02-10T04:48:03.180Z,Epilepsy
SZT2,HGNC:29040,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c3ef40-481f-4e10-a99c-9d208ae9574b-2021-02-02T170000.000Z,2021-02-02T17:00:00.000Z,Epilepsy
TPP1,HGNC:2073,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b2f3b20-fb9a-4b5e-ad8e-e03be5ebb8e5-2020-09-26T005342.102Z,2020-09-26T00:53:42.102Z,Epilepsy
WDR45,HGNC:28912,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85a54036-4d36-414d-8d26-944b9763a039-2019-06-28T160000.000Z,2019-06-28T16:00:00.000Z,Epilepsy
CPAMD8,HGNC:23228,anterior segment dysgenesis 8,MONDO:0015017,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc4d2b2a-08d6-4869-a56e-55721fd4c9dc-2022-11-18T170000.000Z,2022-11-18T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
FOXC1,HGNC:3800,anterior segment dysgenesis 3,MONDO:0024456,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2271229-84ea-4aff-81b4-3428c173ed7b-2021-12-15T031246.818Z,2021-12-15T03:12:46.818Z,Glaucoma and Neuro-Ophthalmology
FOXD3,HGNC:3804,aniridia,MONDO:0019172,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4b3b44d-26d8-4519-9d0d-2259022e79c6-2022-12-15T170000.000Z,2022-12-15T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
NTF4,HGNC:8024,"glaucoma 1, open angle, O",MONDO:0013134,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_144eb479-2c08-47cd-a6d2-8e1abef5cf54-2022-12-15T170000.000Z,2022-12-15T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
OPA1,HGNC:8140,OPA1-related optic atrophy with or without extraocular features,MONDO:0800181,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc3f3ec8-0394-4732-bb4b-d75aaa5bdbcb-2022-11-17T170000.000Z,2022-11-17T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
OPTN,HGNC:17142,"glaucoma, normal tension, susceptibility to",MONDO:0011693,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22efb828-c989-4584-97f9-e1d795b7468f-2022-11-17T170000.000Z,2022-11-17T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
PAX6,HGNC:8620,PAX6-related ocular dysgenesis,MONDO:0800183,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e83f7da-f70f-4f06-a9f9-52bd20219088-2022-06-02T160000.000Z,2022-06-02T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
SSBP1,HGNC:11317,optic atrophy 13 with retinal and foveal abnormalities,MONDO:0008135,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51701b05-3956-4d7b-adc7-7ba4192e8283-2021-05-20T160000.000Z,2021-05-20T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
TEK,HGNC:11724,TEK-related primary glaucoma,MONDO:0800182,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20f13e3f-f927-46c1-b5ed-919f696a7687-2022-08-18T160000.000Z,2022-08-18T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
WDR36,HGNC:30696,"glaucoma 1, open angle, G",MONDO:0012357,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_173858d9-f695-470f-b8b0-22940c60c074-2022-08-18T160000.000Z,2022-08-18T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
ACSL4,HGNC:3571,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9507,2017-10-20T00:00:00,Intellectual Disability and Autism
ADNP,HGNC:15766,ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder,MONDO:0014379,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_837200e1-ed55-415b-bd9e-6649e4abab1d-2020-01-15T170000.000Z,2020-01-15T17:00:00.000Z,Intellectual Disability and Autism
ADSL,HGNC:291,adenylosuccinate lyase deficiency,MONDO:0007068,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d282f565-84e4-4a47-9acc-77ee31bbe9f6-2020-09-07T160000.000Z,2020-09-07T16:00:00.000Z,Intellectual Disability and Autism
AFF2,HGNC:3776,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab4216e3-61b7-4542-ad3a-8788a7ef8b63-2017-10-20T040000.000Z,2017-10-20T04:00:00.000Z,Intellectual Disability and Autism
AGTR2,HGNC:338,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7cfa2a0-e6a7-49b8-a773-b32a1dfbcd57-2020-06-02T160000.000Z,2020-06-02T16:00:00.000Z,Intellectual Disability and Autism
AHDC1,HGNC:25230,AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome,MONDO:0014358,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59a6c010-95ac-4813-9cf4-5ff60fa5c7e9-2021-11-16T170000.000Z,2021-11-16T17:00:00.000Z,Intellectual Disability and Autism
ALDH5A1,HGNC:408,succinic semialdehyde dehydrogenase deficiency,MONDO:0010083,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c3e57466-df2f-4045-b374-010dbd334bfc-2021-04-27T160000.000Z,2021-04-27T16:00:00.000Z,Intellectual Disability and Autism
ALG6,HGNC:23157,ALG6-congenital disorder of glycosylation 1C,MONDO:0011291,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a243ba1-c323-4fde-a7d2-74892c6ab367-2022-11-11T190000.000Z,2022-11-11T19:00:00.000Z,Intellectual Disability and Autism
ANK2,HGNC:493,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_097e646b-467f-4c08-95d6-958ed324562b-2020-12-15T175241.108Z,2020-12-15T17:52:41.108Z,Intellectual Disability and Autism
ANK3,HGNC:494,intellectual disability,MONDO:0001071,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668a89e3-477d-434c-8ab4-0bc9ec3504de-2020-10-07T160000.000Z,2020-10-07T16:00:00.000Z,Intellectual Disability and Autism
ANKRD11,HGNC:21316,KBG syndrome,MONDO:0007846,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf3e887e-8da4-45ea-bec8-9565f8246bc9-2019-11-26T170000.000Z,2019-11-26T17:00:00.000Z,Intellectual Disability and Autism
AP1S2,HGNC:560,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9caaaacd-e262-421c-826b-8433848721ff-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
AP4B1,HGNC:572,AP-4 deficiency syndrome,MONDO:0100176,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4436344a-e0da-4c42-b06a-cdf8a2581ce5-2021-07-26T160000.000Z,2021-07-26T16:00:00.000Z,Intellectual Disability and Autism
AP4E1,HGNC:573,AP-4 deficiency syndrome,MONDO:0100176,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be93d2e7-f302-41a7-9675-032510e46ad2-2021-02-18T155050.880Z,2021-02-18T15:50:50.880Z,Intellectual Disability and Autism
AP4M1,HGNC:574,AP-4 deficiency syndrome,MONDO:0100176,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f49be3e4-4e1f-478b-b4e0-f41623e5b548-2021-04-07T160000.000Z,2021-04-07T16:00:00.000Z,Intellectual Disability and Autism
ARHGEF6,HGNC:685,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d248ef99-6ff8-43d8-a24e-dfce6b2db1c8-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism
ARHGEF9,HGNC:14561,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9305fb2c-6cdf-492d-9dd0-8b03dd4fab1c-2019-11-21T170000.000Z,2019-11-21T17:00:00.000Z,Intellectual Disability and Autism
ARID1A,HGNC:11110,Coffin-Siris syndrome,MONDO:0015452,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aaf6d47a-656a-49ca-ba9e-169f25bf03e7-2021-07-07T160000.000Z,2021-07-07T16:00:00.000Z,Intellectual Disability and Autism
ARID1B,HGNC:18040,Coffin-Siris syndrome,MONDO:0015452,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d487e6c4-9727-4315-90a2-11338128a8e5-2019-12-04T200734.569Z,2019-12-04T20:07:34.569Z,Intellectual Disability and Autism
ARX,HGNC:18060,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccf3ab49-ee8f-4980-aa04-ca13c21c124a-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Intellectual Disability and Autism
ASXL1,HGNC:18318,Bohring-Opitz syndrome,MONDO:0011510,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31e0ce4d-aeb7-4983-9ec2-85178d7f40f0-2021-07-30T160000.000Z,2021-07-30T16:00:00.000Z,Intellectual Disability and Autism
ASXL2,HGNC:23805,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cedd313e-b43b-4212-840b-7d4172258b16-2021-09-28T115443.696Z,2021-09-28T11:54:43.696Z,Intellectual Disability and Autism
ASXL3,HGNC:29357,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_947933aa-f0f8-4909-abd8-2984dd11dcb8-2021-10-06T040000.000Z,2021-10-06T04:00:00.000Z,Intellectual Disability and Autism
ATP13A2,HGNC:30213,Kufor-Rakeb syndrome,MONDO:0011706,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4-2022-04-14T160000.000Z,2022-04-14T16:00:00.000Z,Intellectual Disability and Autism
ATP6AP2,HGNC:18305,ATP6AP2-related disorder,MONDO:0100146,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac33652a-dd98-46f4-ba4e-d3d5a482a22e-2020-09-14T160000.000Z,2020-09-14T16:00:00.000Z,Intellectual Disability and Autism
ATP7A,HGNC:869,Menkes disease,MONDO:0010651,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bc50734-316b-47db-ba10-61f3fde46cca-2018-02-07T170000.000Z,2018-02-07T17:00:00.000Z,Intellectual Disability and Autism
ATRX,HGNC:886,ATR-X-related syndrome,MONDO:0016980,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5296ecdf-b709-47bd-9032-daec8b91e300-2021-09-29T160000.000Z,2021-09-29T16:00:00.000Z,Intellectual Disability and Autism
AUTS2,HGNC:14262,syndromic intellectual disability,MONDO:0000508,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_582999f6-b3b4-46de-90a0-8f44e22df469-2020-09-01T160000.000Z,2020-09-01T16:00:00.000Z,Intellectual Disability and Autism
AVPR1A,HGNC:895,autism spectrum disorder,MONDO:0005258,Undetermined,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ea232de-063f-489a-b00a-8c5d11dbe43a-2022-03-01T050000.000Z,2022-03-01T05:00:00.000Z,Intellectual Disability and Autism
BAZ2B,HGNC:963,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be8c5c40-5fe7-4247-b1d2-b11ca339b365-2022-10-19T040000.000Z,2022-10-19T04:00:00.000Z,Intellectual Disability and Autism
BCL11A,HGNC:13221,Dias-Logan syndrome,MONDO:0014914,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9630f9a3-3f90-49c6-ae8b-6313c950b1b2-2020-09-13T171807.228Z,2020-09-13T17:18:07.228Z,Intellectual Disability and Autism
BPTF,HGNC:3581,syndromic intellectual disability,MONDO:0000508,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08521bf8-a5a2-4a44-941b-12d9eae7aa4f-2022-07-06T160000.000Z,2022-07-06T16:00:00.000Z,Intellectual Disability and Autism
BRD4,HGNC:13575,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b28cda3-bce6-4a8f-b359-0ab398a1111d-2022-04-20T160000.000Z,2022-04-20T16:00:00.000Z,Intellectual Disability and Autism
BRSK2,HGNC:11405,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_327881a5-52fd-42bd-a500-c94514a7aed3-2021-02-03T170000.000Z,2021-02-03T17:00:00.000Z,Intellectual Disability and Autism
BRWD3,HGNC:17342,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8a924e2-e76b-4363-bf38-d95fd53d6141-2018-07-18T160000.000Z,2018-07-18T16:00:00.000Z,Intellectual Disability and Autism
CACNG2,HGNC:1406,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a61ad78f-0f37-4221-82f4-710275033666-2021-07-29T210333.496Z,2021-07-29T21:03:33.496Z,Intellectual Disability and Autism
CASK,HGNC:1497,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca0e703c-3fe1-44a1-8632-036554b2f158-2019-07-09T160000.000Z,2019-07-09T16:00:00.000Z,Intellectual Disability and Autism
CC2D1A,HGNC:30237,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_63def86b-765e-4f12-93a3-94ef911c3190-2020-01-08T170000.000Z,2020-01-08T17:00:00.000Z,Intellectual Disability and Autism
CDH15,HGNC:1754,intellectual disability,MONDO:0001071,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9295bddb-d61c-47c2-b186-97296b9c4d94-2021-02-17T170000.000Z,2021-02-17T17:00:00.000Z,Intellectual Disability and Autism
CDK13,HGNC:1733,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c594bcfa-2b2c-425a-8285-74bae8e01da8-2021-12-31T225720.705Z,2021-12-31T22:57:20.705Z,Intellectual Disability and Autism
CDK16,HGNC:8749,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93557c1a-c141-4833-bcbb-83fccbd7d761-2021-10-28T160000.000Z,2021-10-28T16:00:00.000Z,Intellectual Disability and Autism
CHD3,HGNC:1918,Snijders Blok-Campeau syndrome,MONDO:0032600,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e94c7c1-9c13-4189-8a9f-e9808916526f-2022-03-02T170000.000Z,2022-03-02T17:00:00.000Z,Intellectual Disability and Autism
CHD8,HGNC:20153,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3134b4e1-2fee-4025-99af-b2146cc2ccf8-2018-07-16T160000.000Z,2018-07-16T16:00:00.000Z,Intellectual Disability and Autism
CLCN4,HGNC:2022,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54fbcbc8-77d7-4496-8527-1171cdd7452c-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
CLIC2,HGNC:2063,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e8ec6b8-5189-43eb-a741-833c77e7ce91-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism
CNKSR2,HGNC:19701,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_420ee599-c745-43b9-b9a9-c80dfd7f68a8-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Intellectual Disability and Autism
CNOT3,HGNC:7879,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_585384c5-8958-4934-af26-4040774a644c-2021-08-24T160000.000Z,2021-08-24T16:00:00.000Z,Intellectual Disability and Autism
CNTNAP2,HGNC:13830,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e91dc4be-821d-4f54-acdd-755a25070eec-2021-03-16T160000.000Z,2021-03-16T16:00:00.000Z,Intellectual Disability and Autism
CRADD,HGNC:2340,syndromic intellectual disability,MONDO:0000508,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f64ee7f-13a7-4a2d-b1a2-ad6c9e63cab3-2021-06-16T180000.000Z,2021-06-16T18:00:00.000Z,Intellectual Disability and Autism
CRBN,HGNC:30185,intellectual disability,MONDO:0001071,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_158c9b6b-2ac8-4ee3-bd89-a57d567e675f-2021-05-21T135046.004Z,2021-05-21T13:50:46.004Z,Intellectual Disability and Autism
CREBBP,HGNC:2348,Rubinstein-Taybi syndrome,MONDO:0019188,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d16df64b-26ed-4f1c-b8dc-f27be773b102-2018-04-27T160000.000Z,2018-04-27T16:00:00.000Z,Intellectual Disability and Autism
CTCF,HGNC:13723,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1cbcd7b-83e2-47c1-b708-c9052502e639-2021-07-21T160000.000Z,2021-07-21T16:00:00.000Z,Intellectual Disability and Autism
CTNNB1,HGNC:2514,severe intellectual disability-progressive spastic diplegia syndrome,MONDO:0014035,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e119aceb-a011-4811-9abd-6731c5b3d15d-2021-02-03T170000.000Z,2021-02-03T17:00:00.000Z,Intellectual Disability and Autism
CUL3,HGNC:2553,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb529ace-86b5-4209-9974-9c07a1c32956-2021-01-16T030942.670Z,2021-01-16T03:09:42.670Z,Intellectual Disability and Autism
CUL4B,HGNC:2555,"X-linked intellectual disability, Cabezas type",MONDO:0010306,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc93f3b2-3124-40f8-a86e-c929b09c6f68-2018-02-21T050000.000Z,2018-02-21T05:00:00.000Z,Intellectual Disability and Autism
DDX3X,HGNC:2745,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b7c89d4-ccb2-4d4e-ad11-9d6051a40b6d-2020-05-05T160000.000Z,2020-05-05T16:00:00.000Z,Intellectual Disability and Autism
DHCR7,HGNC:2860,Smith-Lemli-Opitz syndrome,MONDO:0010035,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5ed71c9-a76b-44c0-b5c0-44d604f2e0e9-2018-09-09T160000.000Z,2018-09-09T16:00:00.000Z,Intellectual Disability and Autism
DKC1,HGNC:2890,DKC1-related disorder,MONDO:0100152,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afd6a4ca-7a1c-42ef-a9cf-bef557128f12-2020-09-13T153338.000Z,2020-09-13T15:33:38.000Z,Intellectual Disability and Autism
DLG3,HGNC:2902,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e73a08f0-ff3a-4328-9020-89102296e405-2018-08-15T160000.000Z,2018-08-15T16:00:00.000Z,Intellectual Disability and Autism
DLGAP2,HGNC:2906,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efeafdd5-9105-470f-b332-8c7a3dd65078-2021-10-14T160000.000Z,2021-10-14T16:00:00.000Z,Intellectual Disability and Autism
DPP6,HGNC:3010,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d41cebe-5490-419d-882d-4f3c6856be07-2021-05-05T160000.000Z,2021-05-05T16:00:00.000Z,Intellectual Disability and Autism
DYRK1A,HGNC:3091,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b336707e-f3a5-4554-9b37-0d29621b3562-2020-07-15T195802.528Z,2020-07-15T19:58:02.528Z,Intellectual Disability and Autism
EED,HGNC:3188,Cohen-Gibson syndrome,MONDO:0060510,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44531e19-7957-424f-81e9-fc455095f14a-2022-12-06T190000.000Z,2022-12-06T19:00:00.000Z,Intellectual Disability and Autism
EFTUD2,HGNC:30858,mandibulofacial dysostosis-microcephaly syndrome,MONDO:0012516,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_66012775-240c-4640-ac66-12647021eee5-2022-07-20T160000.000Z,2022-07-20T16:00:00.000Z,Intellectual Disability and Autism
EHMT1,HGNC:24650,Kleefstra syndrome,MONDO:0012455,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db91a861-6a88-4848-b6d5-4772bdef52ff-2018-06-07T040000.000Z,2018-06-07T04:00:00.000Z,Intellectual Disability and Autism
EIF2S3,HGNC:3267,MEHMO syndrome,MONDO:0010258,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb96fe11-dd31-47b2-820d-9071035ec7b0-2021-11-11T170000.000Z,2021-11-11T17:00:00.000Z,Intellectual Disability and Autism
EN2,HGNC:3343,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91eb2fc6-864c-4a4a-9b2d-0b2bdd695999-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism
EPB41L1,HGNC:3378,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3be1f426-ad87-4540-9582-a9dcf96ffddd-2022-07-06T160000.000Z,2022-07-06T16:00:00.000Z,Intellectual Disability and Autism
EZH2,HGNC:3527,Weaver syndrome,MONDO:0010193,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5dcf5941-6076-4486-94be-7ba3944abaee-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Intellectual Disability and Autism
FBN1,HGNC:3603,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42caf14d-6400-475b-88f3-a8a24a0832c0-2021-12-01T190000.000Z,2021-12-01T19:00:00.000Z,Intellectual Disability and Autism
FGD1,HGNC:3663,"Aarskog-Scott syndrome, X-linked",MONDO:0010589,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4b652280-1291-4166-ac59-62caabd977bb-2017-12-06T170000.000Z,2017-12-06T17:00:00.000Z,Intellectual Disability and Autism
FLNA,HGNC:3754,periventricular nodular heterotopia,MONDO:0020341,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80bc6280-7c21-4168-8a98-93c31fead5d7-2020-12-27T231155.213Z,2020-12-27T23:11:55.213Z,Intellectual Disability and Autism
FMR1,HGNC:3775,fragile X syndrome,MONDO:0010383,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e491d278-7123-434c-8de3-46e16afb4037-2019-06-03T160000.000Z,2019-06-03T16:00:00.000Z,Intellectual Disability and Autism
FOLR1,HGNC:3791,neurodegenerative syndrome due to cerebral folate transport deficiency,MONDO:0013110,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22c12588-dc55-4e90-827a-d7a6349e38a9-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
FOXP1,HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db1c240c-7ffb-4a95-92ad-da9e8af2adc6-2019-05-09T162756.956Z,2019-05-09T16:27:56.956Z,Intellectual Disability and Autism
FOXP2,HGNC:13875,specific language disorder,MONDO:0016226,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b13348d1-1248-4507-aa29-60559e6b410e-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Intellectual Disability and Autism
FRMPD4,HGNC:29007,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdc39072-6ab1-4ec6-af69-ce7a2f874f1b-2022-11-02T160000.000Z,2022-11-02T16:00:00.000Z,Intellectual Disability and Autism
FTSJ1,HGNC:13254,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9515,2018-01-17T00:00:00,Intellectual Disability and Autism
GATAD2B,HGNC:30778,severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,MONDO:0014034,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fb40641-ec79-4fee-9111-d38d2062c15b-2022-02-01T170000.000Z,2022-02-01T17:00:00.000Z,Intellectual Disability and Autism
GDI1,HGNC:4226,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8afc42b0-6c5e-460b-87d1-035c051fe7ca-2018-05-24T225528.461Z,2018-05-24T22:55:28.461Z,Intellectual Disability and Autism
GNAI1,HGNC:4384,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea8128fc-f085-492a-b0ef-f37d994bb01b-2021-03-17T160000.000Z,2021-03-17T16:00:00.000Z,Intellectual Disability and Autism
GPC3,HGNC:4451,Simpson-Golabi-Behmel syndrome,MONDO:0010731,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b8b02d6-1d60-4b4c-bb8a-b976907087c7-2019-12-31T175422.159Z,2019-12-31T17:54:22.159Z,Intellectual Disability and Autism
GRIA3,HGNC:4573,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7-2019-11-06T170000.000Z,2019-11-06T17:00:00.000Z,Intellectual Disability and Autism
GRIK2,HGNC:4580,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1939b90b-f1e4-4426-9f8c-5526f9003f10-2022-02-10T180000.000Z,2022-02-10T18:00:00.000Z,Intellectual Disability and Autism
GRIK2,HGNC:4580,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f1b4733-9b55-401b-bc3b-6ead723e7fcb-2022-02-10T180000.000Z,2022-02-10T18:00:00.000Z,Intellectual Disability and Autism
HCFC1,HGNC:4839,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_023defeb-36f4-4e54-ba8f-e2c9537e933c-2021-03-17T160000.000Z,2021-03-17T16:00:00.000Z,Intellectual Disability and Autism
HDAC8,HGNC:13315,Cornelia de Lange syndrome,MONDO:0016033,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7d29159-4c90-488e-a4e1-b006d70ae762-2018-09-11T160000.000Z,2018-09-11T16:00:00.000Z,Intellectual Disability and Autism
HNRNPK,HGNC:5044,neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome,MONDO:0018681,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1adc74c-9bbc-48fc-bbbf-1159c0944108-2021-12-20T170000.000Z,2021-12-20T17:00:00.000Z,Intellectual Disability and Autism
HNRNPU,HGNC:5048,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2c82248-c128-4d3e-802a-7f3295d14455-2022-11-10T190000.000Z,2022-11-10T19:00:00.000Z,Intellectual Disability and Autism
HOXA1,HGNC:5099,syndromic intellectual disability,MONDO:0000508,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e0e605f-c82a-4e34-b913-8dc6b72b4881-2019-06-19T160000.000Z,2019-06-19T16:00:00.000Z,Intellectual Disability and Autism
HPRT1,HGNC:5157,Lesch-Nyhan syndrome,MONDO:0010298,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f60022bb-5679-4766-ac72-2ddfd0b752ee-2022-07-08T160000.000Z,2022-07-08T16:00:00.000Z,Intellectual Disability and Autism
HUWE1,HGNC:30892,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ded2ea2f-63ff-428a-8061-7c62c276163b-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
IDS,HGNC:5389,mucopolysaccharidosis type 2,MONDO:0010674,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_753ba7a6-cef5-4665-81e9-306e11c618c5-2018-02-21T170000.000Z,2018-02-21T17:00:00.000Z,Intellectual Disability and Autism
IGBP1,HGNC:5461,corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,MONDO:0010333,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbeb1651-add0-4a44-87ad-a56c7864f076-2021-02-02T170000.000Z,2021-02-02T17:00:00.000Z,Intellectual Disability and Autism
IL1RAPL1,HGNC:5996,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b5db6b4-94fa-46d1-88a7-bbf382f3a1c6-2021-03-15T135028.460Z,2021-03-15T13:50:28.460Z,Intellectual Disability and Autism
IQSEC2,HGNC:29059,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0916cda1-5213-4f88-9835-34c3931526a2-2019-06-05T160000.000Z,2019-06-05T16:00:00.000Z,Intellectual Disability and Autism
ITPR1,HGNC:6180,spinocerebellar ataxia type 29,MONDO:0007298,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b938bea-6fcb-46e1-9435-99303d59740e-2021-11-03T160000.000Z,2021-11-03T16:00:00.000Z,Intellectual Disability and Autism
ITPR1,HGNC:6180,aniridia-cerebellar ataxia-intellectual disability syndrome,MONDO:0008795,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a848b265-8aa3-41ee-83cc-9287afe0f9d0-2021-11-03T160000.000Z,2021-11-03T16:00:00.000Z,Intellectual Disability and Autism
KANSL1,HGNC:24565,Koolen-de Vries syndrome,MONDO:0012496,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e89a0e87-314a-49b1-bb50-6b26aeaa1037-2022-02-18T120936.714Z,2022-02-18T12:09:36.714Z,Intellectual Disability and Autism
KAT6A,HGNC:13013,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86ec74ba-6b12-42ea-bc06-58af4fd6b7a4-2021-10-05T160000.000Z,2021-10-05T16:00:00.000Z,Intellectual Disability and Autism
KATNAL2,HGNC:25387,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eddbdd3e-2f6b-4b55-a951-988ee214b08b-2020-05-20T160000.000Z,2020-05-20T16:00:00.000Z,Intellectual Disability and Autism
KCNH1,HGNC:6250,KCNH1 associated disorder,MONDO:0100485,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b090a30-6065-4337-b930-d40585b142cd-2022-04-05T160000.000Z,2022-04-05T16:00:00.000Z,Intellectual Disability and Autism
KDM5B,HGNC:18039,intellectual disability,MONDO:0001071,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ae3441f-82f6-4985-ba48-fd1de8ea6ce4-2022-03-01T170000.000Z,2022-03-01T17:00:00.000Z,Intellectual Disability and Autism
KDM5C,HGNC:11114,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_36896d71-1c04-4176-8cd9-16f5b283ef9c-2018-09-19T160000.000Z,2018-09-19T16:00:00.000Z,Intellectual Disability and Autism
KDM6B,HGNC:29012,syndromic intellectual disability,MONDO:0000508,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_010fe1d1-312f-45fa-93ca-887875c53607-2022-02-18T170000.000Z,2022-02-18T17:00:00.000Z,Intellectual Disability and Autism
KDM6B,HGNC:29012,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_37e4fa5a-05b7-4cee-b43a-eb58488346bd-2022-01-19T170000.000Z,2022-01-19T17:00:00.000Z,Intellectual Disability and Autism
KIF1A,HGNC:888,syndromic intellectual disability,MONDO:0000508,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d586d93-7066-4db0-b623-8b7e3eafdc06-2020-09-24T134254.893Z,2020-09-24T13:42:54.893Z,Intellectual Disability and Autism
KMT2C,HGNC:13726,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1dcdd6c-30e0-4d06-8df5-f120b1b02477-2022-03-02T170000.000Z,2022-03-02T17:00:00.000Z,Intellectual Disability and Autism
L1CAM,HGNC:6470,L1 syndrome,MONDO:0017140,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8541f5b-a166-44cd-a7f3-fce263ef8fde-2019-10-02T160000.000Z,2019-10-02T16:00:00.000Z,Intellectual Disability and Autism
LAMC3,HGNC:6494,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ff89702-c97e-4ef9-91ce-2e37b66efd84-2020-09-01T160000.000Z,2020-09-01T16:00:00.000Z,Intellectual Disability and Autism
LAS1L,HGNC:25726,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5b85dbb-3d49-4924-8294-e518ff56f048-2021-09-21T160000.000Z,2021-09-21T16:00:00.000Z,Intellectual Disability and Autism
MAGEL2,HGNC:6814,Schaaf-Yang syndrome,MONDO:0014243,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa89f10b-6ccf-4c69-aef3-fc2f6c8e6ea9-2021-06-01T160000.000Z,2021-06-01T16:00:00.000Z,Intellectual Disability and Autism
MAN1B1,HGNC:6823,MAN1B1-congenital disorder of glycosylation,MONDO:0018349,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0f50bc5-f7ac-4e0a-9762-d6cad9cc4585-2020-08-04T114702.993Z,2020-08-04T11:47:02.993Z,Intellectual Disability and Autism
MAOA,HGNC:6833,Brunner syndrome,MONDO:0010379,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20ffc014-ef31-4693-91c4-424bbe1e48dd-2020-04-14T203950.820Z,2020-04-14T20:39:50.820Z,Intellectual Disability and Autism
MBD5,HGNC:20444,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_952cb4f8-e59b-4edb-a393-0266e0008963-2018-11-21T170000.000Z,2018-11-21T17:00:00.000Z,Intellectual Disability and Autism
MBTPS2,HGNC:15455,IFAP syndrome with or without BRESHECK syndrome,MONDO:0100213,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13a8a124-1071-4150-b6ea-0165cbf41c2d-2021-05-17T145233.620Z,2021-05-17T14:52:33.620Z,Intellectual Disability and Autism
MED12,HGNC:11957,MED12-related intellectual disability syndrome,MONDO:0100000,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afba0573-9f47-4814-bf3a-ef41f5512dee-2018-04-27T193808.041Z,2018-04-27T19:38:08.041Z,Intellectual Disability and Autism
MED13,HGNC:22474,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e82f63b1-ed0f-4dd0-8168-3aa4e0a4c2a9-2022-05-17T180000.000Z,2022-05-17T18:00:00.000Z,Intellectual Disability and Autism
MED13L,HGNC:22962,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41758f8d-1f99-47fa-beb6-c327fa6cb940-2021-04-21T040000.000Z,2021-04-21T04:00:00.000Z,Intellectual Disability and Autism
MED23,HGNC:2372,syndromic intellectual disability,MONDO:0000508,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e8c75f0-39ae-4967-b95d-a92c55739876-2020-04-01T160000.000Z,2020-04-01T16:00:00.000Z,Intellectual Disability and Autism
MEF2C,HGNC:6996,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_34354e8f-4343-4fba-82ba-e49579e504bb-2019-02-06T170000.000Z,2019-02-06T17:00:00.000Z,Intellectual Disability and Autism
MEIS2,HGNC:7001,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fe156246-6e64-4096-a4c5-a83a3e70dbb9-2022-04-06T160000.000Z,2022-04-06T16:00:00.000Z,Intellectual Disability and Autism
MET,HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d55c61af-ef8e-475d-9ff7-454496cb6462-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Intellectual Disability and Autism
MID1,HGNC:7095,X-linked Opitz G/BBB syndrome,MONDO:0010222,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2471967-d6b3-4ffb-a9fd-e3dbd089cb20-2018-03-21T160000.000Z,2018-03-21T16:00:00.000Z,Intellectual Disability and Autism
MSL3,HGNC:7370,Basilicata-Akhtar syndrome,MONDO:0026730,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f700593e-b7c1-4149-810d-7e71fbea61d0-2022-01-18T170000.000Z,2022-01-18T17:00:00.000Z,Intellectual Disability and Autism
MYT1L,HGNC:7623,syndromic intellectual disability,MONDO:0000508,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_32897f25-e36a-4ec8-9401-0374a95e06a5-2020-08-18T160000.000Z,2020-08-18T16:00:00.000Z,Intellectual Disability and Autism
NAA10,HGNC:18704,NAA10-related syndrome,MONDO:0100124,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcdd3d02-82f3-4ea3-a2b0-8ac2d4c40b1b-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Intellectual Disability and Autism
NAA15,HGNC:30782,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f9732e0c-1306-4fb5-b1b3-873258903e75-2022-01-05T170000.000Z,2022-01-05T17:00:00.000Z,Intellectual Disability and Autism
NBEA,HGNC:7648,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f40357db-6cc2-4240-8771-1206cd27298a-2020-12-02T170000.000Z,2020-12-02T17:00:00.000Z,Intellectual Disability and Autism
NDP,HGNC:7678,Norrie disease,MONDO:0010691,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_335ce5aa-7f87-4b91-a447-928399f40f11-2018-03-21T160000.000Z,2018-03-21T16:00:00.000Z,Intellectual Disability and Autism
NEXMIF,HGNC:29433,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_191437ab-2e73-4a0b-a660-ab5eab4c1066-2020-02-05T170000.000Z,2020-02-05T17:00:00.000Z,Intellectual Disability and Autism
NHS,HGNC:7820,Nance-Horan syndrome,MONDO:0010545,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7f57ca3-efb2-4333-9ae1-732aa429f37a-2017-10-20T040000.000Z,2017-10-20T04:00:00.000Z,Intellectual Disability and Autism
NIPBL,HGNC:28862,Cornelia de Lange syndrome,MONDO:0016033,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4ecc430-6562-4d58-9118-c5253dc95ae9-2018-06-20T144433.262Z,2018-06-20T14:44:33.262Z,Intellectual Disability and Autism
NLGN3,HGNC:14289,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6e7e531-093b-4216-8c56-0c94e63c2811-2018-08-15T040000.000Z,2018-08-15T04:00:00.000Z,Intellectual Disability and Autism
NLGN4X,HGNC:14287,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bed32aec-b1a6-41ff-9607-b4172888c46a-2018-08-01T160000.000Z,2018-08-01T16:00:00.000Z,Intellectual Disability and Autism
NR2F1,HGNC:7975,Bosch-Boonstra-Schaaf optic atrophy syndrome,MONDO:0014320,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1aa4efce-b5b8-4cbd-b043-bb89c5283e3c-2022-02-16T170000.000Z,2022-02-16T17:00:00.000Z,Intellectual Disability and Autism
NR4A2,HGNC:7981,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8923fda-35f3-47e3-a987-8ca2b86e4b92-2021-05-05T160000.000Z,2021-05-05T16:00:00.000Z,Intellectual Disability and Autism
NRXN1,HGNC:8008,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14bb833a-eefd-4f02-b112-c74b6866d5be-2019-07-10T160000.000Z,2019-07-10T16:00:00.000Z,Intellectual Disability and Autism
NSD1,HGNC:14234,Sotos syndrome,MONDO:0019349,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa1a412a-ee7d-4517-81ba-0ceead9668d1-2018-10-26T160000.000Z,2018-10-26T16:00:00.000Z,Intellectual Disability and Autism
NSD2,HGNC:12766,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_de3c113b-0a7d-454d-88e3-faf4f1fdb9ac-2021-06-02T160000.000Z,2021-06-02T16:00:00.000Z,Intellectual Disability and Autism
NSDHL,HGNC:13398,CK syndrome,MONDO:0010441,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d94406f0-a459-47ed-aabc-80c7b6be9293-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Intellectual Disability and Autism
NSUN2,HGNC:25994,intellectual disability,MONDO:0001071,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6878f90-f485-4c44-95d3-a33b0ec9f66f-2019-02-06T170000.000Z,2019-02-06T17:00:00.000Z,Intellectual Disability and Autism
NTNG1,HGNC:23319,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c648acf-5801-481b-a1c4-f950e99d4d96-2021-02-02T170000.000Z,2021-02-02T17:00:00.000Z,Intellectual Disability and Autism
OCRL,HGNC:8108,oculocerebrorenal syndrome,MONDO:0010645,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5140c756-fac0-435b-8f59-a5d4a0b0adb3-2020-07-10T160000.000Z,2020-07-10T16:00:00.000Z,Intellectual Disability and Autism
OFD1,HGNC:2567,ciliopathy,MONDO:0005308,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15e32789-4f24-4870-94d3-b5618e67509f-2018-04-27T165136.294Z,2018-04-27T16:51:36.294Z,Intellectual Disability and Autism
PACS1,HGNC:30032,Schuurs-Hoeijmakers syndrome,MONDO:0014006,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5fb6cba-cff6-4498-a725-3f863a910cf1-2020-06-26T182716.855Z,2020-06-26T18:27:16.855Z,Intellectual Disability and Autism
PAK3,HGNC:8592,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2f13863-a52d-49bd-b7f6-294edd73717a-2018-07-31T160000.000Z,2018-07-31T16:00:00.000Z,Intellectual Disability and Autism
PHF21A,HGNC:24156,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1312f4b-fcc2-46ca-9132-7592e46ae05f-2022-04-06T160000.000Z,2022-04-06T16:00:00.000Z,Intellectual Disability and Autism
PHF6,HGNC:18145,Borjeson-Forssman-Lehmann syndrome,MONDO:0010537,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94ea5014-0a83-49ea-b001-fc2a8c24c0d9-2018-02-21T170000.000Z,2018-02-21T17:00:00.000Z,Intellectual Disability and Autism
PHF8,HGNC:20672,syndromic X-linked intellectual disability Siderius type,MONDO:0010286,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9e94640-1950-4438-bcda-4859545d83d1-2018-11-07T170000.000Z,2018-11-07T17:00:00.000Z,Intellectual Disability and Autism
PHIP,HGNC:15673,PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome,MONDO:0035133,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0635f61b-d8aa-428a-b4d3-0b2d116ece39-2022-04-19T160000.000Z,2022-04-19T16:00:00.000Z,Intellectual Disability and Autism
PLP1,HGNC:9086,Pelizaeus-Merzbacher disease,MONDO:0010714,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1a44c5f-744e-4d02-a08f-e7c687531b21-2018-03-07T170000.000Z,2018-03-07T17:00:00.000Z,Intellectual Disability and Autism
POGZ,HGNC:18801,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,MONDO:0014606,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5742d94-0642-4598-9fbd-fd43a2c21559-2020-03-09T160000.000Z,2020-03-09T16:00:00.000Z,Intellectual Disability and Autism
PORCN,HGNC:17652,focal dermal hypoplasia,MONDO:0010592,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fc3afa-d10d-4239-885f-24e91cbb31a8-2020-08-05T124432.168Z,2020-08-05T12:44:32.168Z,Intellectual Disability and Autism
PPM1D,HGNC:9277,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ec2cb-1632-4439-bdd9-4bcae1bb779f-2022-02-15T170000.000Z,2022-02-15T17:00:00.000Z,Intellectual Disability and Autism
PPP2R1A,HGNC:9302,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1aae8155-7cb1-44ee-9cee-17bb22e6a0ad-2022-11-16T170000.000Z,2022-11-16T17:00:00.000Z,Intellectual Disability and Autism
PPP2R5D,HGNC:9312,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4b43ff91-1ea4-475b-97d9-6fbda924ea16-2022-01-12T055053.721Z,2022-01-12T05:50:53.721Z,Intellectual Disability and Autism
PQBP1,HGNC:9330,Renpenning syndrome,MONDO:0010653,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8128f36b-f273-49ee-bfd8-bee64b4df921-2018-11-09T170000.000Z,2018-11-09T17:00:00.000Z,Intellectual Disability and Autism
PRSS12,HGNC:9477,non-syndromic intellectual disability,MONDO:0000509,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d98f99d6-b1df-4cad-a53b-c94cfb532167-2021-08-04T160000.000Z,2021-08-04T16:00:00.000Z,Intellectual Disability and Autism
PTCHD1,HGNC:26392,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05d36fe2-0026-4bbc-af4b-6d952490969b-2018-08-15T160000.000Z,2018-08-15T16:00:00.000Z,Intellectual Disability and Autism
PUF60,HGNC:17042,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_661c140f-11a3-46f8-b001-14a2314582e4-2021-12-15T170000.000Z,2021-12-15T17:00:00.000Z,Intellectual Disability and Autism
QRICH1,HGNC:24713,syndromic intellectual disability,MONDO:0000508,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ccc6c6f-da19-4e86-88a8-5e7a1794efae-2022-06-15T170000.000Z,2022-06-15T17:00:00.000Z,Intellectual Disability and Autism
RAB39B,HGNC:16499,early-onset parkinsonism-intellectual disability syndrome,MONDO:0010709,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01dc73a8-fbd2-4081-95cd-ab7cb59236d7-2018-06-04T040000.000Z,2018-06-04T04:00:00.000Z,Intellectual Disability and Autism
RAB40AL,HGNC:25410,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_126405bb-ecf5-49a3-b7d5-bb1b45a65e26-2021-06-15T160000.000Z,2021-06-15T16:00:00.000Z,Intellectual Disability and Autism
RAD21,HGNC:9811,Cornelia de Lange syndrome,MONDO:0016033,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_30ad5023-6c68-42ab-b8ea-a601a134eaf6-2020-01-08T170000.000Z,2020-01-08T17:00:00.000Z,Intellectual Disability and Autism
RAI1,HGNC:9834,Smith-Magenis syndrome,MONDO:0008434,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e576e58-debf-49c6-a86d-c599806180ff-2018-09-05T160000.000Z,2018-09-05T16:00:00.000Z,Intellectual Disability and Autism
RELN,HGNC:9957,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c654081c-5abd-4f86-a3f7-90d7f117b93d-2021-03-17T160000.000Z,2021-03-17T16:00:00.000Z,Intellectual Disability and Autism
RPL10,HGNC:10298,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_974ac8bb-f7b1-4480-869a-e9ef4b8b3fa3-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Intellectual Disability and Autism
RPS6KA3,HGNC:10432,Coffin-Lowry syndrome,MONDO:0010561,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af32a931-1d55-432f-82cf-ce87f6c26580-2019-05-28T040000.000Z,2019-05-28T04:00:00.000Z,Intellectual Disability and Autism
SATB2,HGNC:21637,SATB2 associated disorder,MONDO:0100147,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44d14081-fa32-4159-9049-35f510d2351a-2020-09-15T160000.000Z,2020-09-15T16:00:00.000Z,Intellectual Disability and Autism
SET,HGNC:10760,intellectual disability,MONDO:0001071,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4d7c9aa2-0a9a-4359-af98-6097cc6a3b91-2021-11-17T170000.000Z,2021-11-17T17:00:00.000Z,Intellectual Disability and Autism
SETBP1,HGNC:15573,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70505ca8-8869-4fa9-9965-fc8e03a19b28-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism
SETBP1,HGNC:15573,Schinzel-Giedion syndrome,MONDO:0010010,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71885c03-b578-4baf-a17c-4817349eaf36-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism
SHANK2,HGNC:14295,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_911cb9ff-e68e-4b47-8639-f6a63ab11b3e-2019-07-17T160000.000Z,2019-07-17T16:00:00.000Z,Intellectual Disability and Autism
SHANK3,HGNC:14294,Phelan-McDermid syndrome,MONDO:0011652,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e941703a-0f30-4f4c-a997-bc3b4295f289-2018-12-12T170000.000Z,2018-12-12T17:00:00.000Z,Intellectual Disability and Autism
SHROOM4,HGNC:29215,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a94d20f8-9909-48b2-9860-d17c6dc73ec3-2021-01-13T170000.000Z,2021-01-13T17:00:00.000Z,Intellectual Disability and Autism
SIN3A,HGNC:19353,SIN3A-related intellectual disability syndrome,MONDO:0044699,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6bb2ed-0912-4d60-9faa-39be27ecf4c7-2022-01-19T070000.000Z,2022-01-19T07:00:00.000Z,Intellectual Disability and Autism
SLC16A2,HGNC:10923,Allan-Herndon-Dudley syndrome,MONDO:0010354,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9242e32-a339-4426-8ef5-39df0960d390-2018-08-09T170000.000Z,2018-08-09T17:00:00.000Z,Intellectual Disability and Autism
SLC2A1,HGNC:11005,GLUT1 deficiency syndrome,MONDO:0000188,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a20a0bc0-49d5-41fc-9507-cec19a43bd81-2019-04-18T123454.696Z,2019-04-18T12:34:54.696Z,Intellectual Disability and Autism
SLC6A4,HGNC:11050,autism spectrum disorder,MONDO:0005258,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc4b0612-0a53-4e36-b737-5c0f49a387a1-2021-01-06T170000.000Z,2021-01-06T17:00:00.000Z,Intellectual Disability and Autism
SLC9A9,HGNC:20653,autism spectrum disorder,MONDO:0005258,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_463ee005-1264-45da-bd85-3776a6637c68-2020-10-08T160000.000Z,2020-10-08T16:00:00.000Z,Intellectual Disability and Autism
SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z,2021-12-30T17:00:00.000Z,Intellectual Disability and Autism
SMARCA1,HGNC:11097,X-linked intellectual disability,MONDO:0100284,XL,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ce97120a-5094-4768-b305-941353791584-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Intellectual Disability and Autism
SMARCA2,HGNC:11098,intellectual disability-sparse hair-brachydactyly syndrome,MONDO:0011053,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5cde86bc-f99f-40cf-8c32-eac9f8f8a67d-2020-08-18T160000.000Z,2020-08-18T16:00:00.000Z,Intellectual Disability and Autism
SMARCA4,HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61d29c73-9a30-4664-9df2-2f5831219221-2020-06-17T160000.000Z,2020-06-17T16:00:00.000Z,Intellectual Disability and Autism
SMARCC2,HGNC:11105,Coffin-Siris syndrome,MONDO:0015452,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa645aa6-3a03-4ab7-9d09-b17be3184259-2022-02-02T170000.000Z,2022-02-02T17:00:00.000Z,Intellectual Disability and Autism
SMC1A,HGNC:11111,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c281f5fd-d868-4425-a7b4-8e39e3b2090e-2019-06-19T160000.000Z,2019-06-19T16:00:00.000Z,Intellectual Disability and Autism
SMC3,HGNC:2468,Cornelia de Lange syndrome,MONDO:0016033,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9467eaad-a86a-4b24-8cd4-98ebb57121c1-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Intellectual Disability and Autism
SMS,HGNC:11123,syndromic X-linked intellectual disability Snyder type,MONDO:0010664,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f1ca85b-ad57-4c64-9abf-9ae5d915703f-2018-05-16T195543.428Z,2018-05-16T19:55:43.428Z,Intellectual Disability and Autism
SNAP25,HGNC:11132,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5696dbd2-dfe5-4c96-baec-c9d963959b28-2022-03-24T160000.000Z,2022-03-24T16:00:00.000Z,Intellectual Disability and Autism
SOX5,HGNC:11201,Lamb-Shaffer syndrome,MONDO:0014778,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_781f21f2-d01a-457c-913e-8687a7c2650d-2022-01-27T170000.000Z,2022-01-27T17:00:00.000Z,Intellectual Disability and Autism
ST3GAL3,HGNC:10866,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e151129d-46fc-4f7e-a434-e423a3fb644b-2020-06-03T160000.000Z,2020-06-03T16:00:00.000Z,Intellectual Disability and Autism
SYN1,HGNC:11494,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca5a3e64-5daa-4a2f-876d-4e7648c53ff8-2018-12-05T170000.000Z,2018-12-05T17:00:00.000Z,Intellectual Disability and Autism
SYP,HGNC:11506,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0d770a5-873c-4a55-98da-fa8d235ff93b-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Intellectual Disability and Autism
TANC2,HGNC:30212,"intellectual developmental disorder with autistic features and language delay, with or without seizures",MONDO:0030051,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3d3d067-5a78-44b4-9c57-25cc784123bf-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Intellectual Disability and Autism
TAOK1,HGNC:29259,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79c712d0-ac0e-4bf0-8e68-bd598b3bca42-2021-08-04T160000.000Z,2021-08-04T16:00:00.000Z,Intellectual Disability and Autism
TBL1XR1,HGNC:29529,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8352a921-43c0-4097-9147-2618a4165b57-2020-07-07T170000.000Z,2020-07-07T17:00:00.000Z,Intellectual Disability and Autism
TBR1,HGNC:11590,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_853c90ef-34a8-4d7d-931d-5fb4add3e4d0-2020-03-25T160000.000Z,2020-03-25T16:00:00.000Z,Intellectual Disability and Autism
TCF7L2,HGNC:11641,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b11a5317-868b-49a9-b051-721940fb5936-2021-12-15T170000.000Z,2021-12-15T17:00:00.000Z,Intellectual Disability and Autism
TECR,HGNC:4551,intellectual disability,MONDO:0001071,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c7adee2-6a14-4348-a018-9097954bd39d-2022-03-10T170000.000Z,2022-03-10T17:00:00.000Z,Intellectual Disability and Autism
TELO2,HGNC:29099,TELO2-related intellectual disability-neurodevelopmental disorder,MONDO:0014848,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6995e858-919b-4a08-be40-54a56371a408-2022-06-01T160000.000Z,2022-06-01T16:00:00.000Z,Intellectual Disability and Autism
TMLHE,HGNC:18308,autism spectrum disorder,MONDO:0005258,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a780ea6-ad4e-417a-a596-27188e327aad-2021-03-02T050000.000Z,2021-03-02T05:00:00.000Z,Intellectual Disability and Autism
TNRC6B,HGNC:29190,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a806c490-788f-49b6-b437-6970f5888c07-2021-01-06T170000.000Z,2021-01-06T17:00:00.000Z,Intellectual Disability and Autism
TRAPPC9,HGNC:30832,intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,MONDO:0018123,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_456bfabf-5cad-4a08-bf21-3611a6fbf9b1-2020-08-15T160000.000Z,2020-08-15T16:00:00.000Z,Intellectual Disability and Autism
TRIM8,HGNC:15579,focal segmental glomerulosclerosis and neurodevelopmental syndrome,MONDO:0100111,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_457fd90a-dad8-4711-97d0-59eb240a299e-2021-10-06T160000.000Z,2021-10-06T16:00:00.000Z,Intellectual Disability and Autism
TRIO,HGNC:12303,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff3b6c9b-4c51-4414-b92c-20e45758ab61-2021-11-18T192046.961Z,2021-11-18T19:20:46.961Z,Intellectual Disability and Autism
TRIP12,HGNC:12306,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_011b99b3-0d17-4615-800e-36f4bacd8117-2022-04-05T063000.000Z,2022-04-05T06:30:00.000Z,Intellectual Disability and Autism
TRRAP,HGNC:12347,complex neurodevelopmental disorder with or without congenital anomalies,MONDO:0100465,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03424cde-a847-4bd0-91eb-9707a7e51fa2-2022-07-19T180000.000Z,2022-07-19T18:00:00.000Z,Intellectual Disability and Autism
TSPAN7,HGNC:11854,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2716e7b3-e038-421a-b584-55f6797502a4-2020-12-02T170000.000Z,2020-12-02T17:00:00.000Z,Intellectual Disability and Autism
TUSC3,HGNC:30242,intellectual disability,MONDO:0001071,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db38ed95-d1fe-43d6-bf80-c5e3f24f7d1b-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Intellectual Disability and Autism
UBE2A,HGNC:12472,syndromic X-linked intellectual disability Nascimento type,MONDO:0010461,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94765cdb-fe12-4098-b28e-20cd58744271-2018-07-02T160000.000Z,2018-07-02T16:00:00.000Z,Intellectual Disability and Autism
UPF3B,HGNC:20439,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1caf030-ef58-4f8f-ba40-aabbf81cf6b1-2019-07-03T160000.000Z,2019-07-03T16:00:00.000Z,Intellectual Disability and Autism
USP9X,HGNC:12632,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bd411e83-8373-44b7-8ad5-00894c873880-2021-11-17T180000.000Z,2021-11-17T18:00:00.000Z,Intellectual Disability and Autism
VPS13B,HGNC:2183,Cohen syndrome,MONDO:0008999,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccfc68bc-9f00-4565-b2c7-70ad9f8e2002-2018-11-13T153457.342Z,2018-11-13T15:34:57.342Z,Intellectual Disability and Autism
WAC,HGNC:17327,DeSanto-Shinawi syndrome,MONDO:0018760,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a1f3c78-d7d2-4a8c-8dbf-ddda78769bd7-2022-11-10T170000.000Z,2022-11-10T17:00:00.000Z,Intellectual Disability and Autism
WDFY3,HGNC:20751,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9300a41-dcac-4842-855d-01804e18d599-2022-01-19T170000.000Z,2022-01-19T17:00:00.000Z,Intellectual Disability and Autism
ZC4H2,HGNC:24931,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_64ba9cd6-bdfd-4b85-9bdd-1b317715230d-2020-10-21T002026.894Z,2020-10-21T00:20:26.894Z,Intellectual Disability and Autism
ZDHHC15,HGNC:20342,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2519945-2acd-4484-9811-487ff5189da9-2021-07-30T160000.000Z,2021-07-30T16:00:00.000Z,Intellectual Disability and Autism
ZDHHC9,HGNC:18475,syndromic X-linked intellectual disability Raymond type,MONDO:0010427,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2156b925-1ee6-4edb-a514-3650aa5b780e-2020-05-19T160000.000Z,2020-05-19T16:00:00.000Z,Intellectual Disability and Autism
ZEB2,HGNC:14881,Mowat-Wilson syndrome,MONDO:0009341,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cb06ff0d-1cc6-494c-9ce5-f7cb26f34620-2018-05-24T160000.000Z,2018-05-24T16:00:00.000Z,Intellectual Disability and Autism
ZMIZ1,HGNC:16493,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6047476-9d50-4b42-a00a-e983c7481f19-2022-07-05T020000.000Z,2022-07-05T02:00:00.000Z,Intellectual Disability and Autism
ZNF292,HGNC:18410,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dba438b7-23f9-4c15-a8aa-f70431a193e2-2020-05-06T160000.000Z,2020-05-06T16:00:00.000Z,Intellectual Disability and Autism
ZNF41,HGNC:13107,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d705685-78a3-4925-8a1b-e00d39d63f87-2021-03-16T171235.415Z,2021-03-16T17:12:35.415Z,Intellectual Disability and Autism
ZNF674,HGNC:17625,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5105ab37-4f59-44dc-a8b1-f28e6ed3b704-2021-05-04T170000.000Z,2021-05-04T17:00:00.000Z,Intellectual Disability and Autism
ZNF711,HGNC:13128,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80a6e42d-f8ce-4bce-8bb4-579b78c94d21-2022-09-22T060000.000Z,2022-09-22T06:00:00.000Z,Intellectual Disability and Autism
ZNF81,HGNC:13156,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a3ada757-6500-46a1-a89e-42668bbdb934-2021-01-26T170000.000Z,2021-01-26T17:00:00.000Z,Intellectual Disability and Autism
ADAR,HGNC:225,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03f538b5-43af-4699-9ddb-264077de21c9-2020-08-27T164642.352Z,2020-08-27T16:46:42.352Z,Leigh syndrome
AIFM1,HGNC:8768,Leigh syndrome,MONDO:0009723,XL,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e917f93b-01ef-42e3-bf8d-b50a91f83f9c-2021-06-14T135732.582Z,2021-06-14T13:57:32.582Z,Leigh syndrome
ATP5MK,HGNC:30889,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff19a86d-404a-464e-8da6-8824ce45ed20-2020-08-27T164252.070Z,2020-08-27T16:42:52.070Z,Leigh syndrome
BCS1L,HGNC:1020,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b50d7db-1144-4187-a60c-72b45adb80bd-2019-09-19T155315.896Z,2019-09-19T15:53:15.896Z,Leigh syndrome
BTD,HGNC:1122,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74599afe-02f9-4225-9e50-63306f04a552-2021-06-14T140327.018Z,2021-06-14T14:03:27.018Z,Leigh syndrome
CLPB,HGNC:30664,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_789c591d-1de7-4652-a0d1-f895b639233e-2020-11-23T201057.415Z,2020-11-23T20:10:57.415Z,Leigh syndrome
COQ9,HGNC:25302,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cebc5501-5d36-4767-98bc-edc4ddab3527-2021-04-09T140634.407Z,2021-04-09T14:06:34.407Z,Leigh syndrome
COX10,HGNC:2260,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48794019-db9d-47c2-9977-4dc76a7d07b3-2019-05-20T182801.393Z,2019-05-20T18:28:01.393Z,Leigh syndrome
COX15,HGNC:2263,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c8d1e1-24d0-4b88-8c04-023197db14f3-2019-05-20T183321.284Z,2019-05-20T18:33:21.284Z,Leigh syndrome
COX4I1,HGNC:2265,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d56c1fe4-7711-45f4-992c-7e9586b9efc6-2021-04-09T135824.042Z,2021-04-09T13:58:24.042Z,Leigh syndrome
COX8A,HGNC:2294,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70763eb9-40f7-4f71-a64b-ab0c6ad536b0-2021-04-09T135510.592Z,2021-04-09T13:55:10.592Z,Leigh syndrome
DLAT,HGNC:2896,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78e45dbe-ea30-434d-9522-aa1731b9a764-2021-01-14T212056.234Z,2021-01-14T21:20:56.234Z,Leigh syndrome
DLD,HGNC:2898,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_990dd96f-16ec-4c0f-a46b-ce4a647b7a50-2021-03-11T171246.198Z,2021-03-11T17:12:46.198Z,Leigh syndrome
DNM1L,HGNC:2973,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a922695-f136-44f8-ab1a-6581e0efafec-2021-06-30T144517.300Z,2021-06-30T14:45:17.300Z,Leigh syndrome
DNM1L,HGNC:2973,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c22e9c6b-f04d-4d56-acb3-baa308c596b7-2021-06-30T144120.695Z,2021-06-30T14:41:20.695Z,Leigh syndrome
EARS2,HGNC:29419,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_774e378c-2636-41ad-be48-a2c00328ab9c-2020-03-19T190729.531Z,2020-03-19T19:07:29.531Z,Leigh syndrome
ECHS1,HGNC:3151,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d443f3c-fe02-4104-9e92-ca1c73b85a81-2021-04-09T142601.823Z,2021-04-09T14:26:01.823Z,Leigh syndrome
ETHE1,HGNC:23287,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d29d908d-ea85-4eb4-a6a5-400c95511c9a-2019-04-08T161759.443Z,2019-04-08T16:17:59.443Z,Leigh syndrome
FARS2,HGNC:21062,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf7594a-d934-4b6c-8052-94066d608c5a-2019-11-25T144756.827Z,2019-11-25T14:47:56.827Z,Leigh syndrome
FBXL4,HGNC:13601,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fed67104-182c-48f2-85c0-ecb05cd6dd72-2020-11-23T193117.246Z,2020-11-23T19:31:17.246Z,Leigh syndrome
FOXRED1,HGNC:26927,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c74ba0cb-ccef-4a19-9fef-ef9996f72290-2019-10-16T143453.574Z,2019-10-16T14:34:53.574Z,Leigh syndrome
GFM1,HGNC:13780,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_154a8f96-7062-49c7-9aaa-b23a98655f40-2019-12-19T185108.232Z,2019-12-19T18:51:08.232Z,Leigh syndrome
GFM2,HGNC:29682,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0736b760-ca37-4d0a-93a4-c71bbb8cd41a-2019-12-19T185449.252Z,2019-12-19T18:54:49.252Z,Leigh syndrome
GTPBP3,HGNC:14880,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0d1b0a47-e62d-48dd-8e0d-f2b1aff014a7-2020-02-12T203256.857Z,2020-02-12T20:32:56.857Z,Leigh syndrome
HIBCH,HGNC:4908,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_079ed613-0c28-494f-9852-9baf495f26ba-2021-06-14T142317.786Z,2021-06-14T14:23:17.786Z,Leigh syndrome
HPDL,HGNC:28242,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1a484ba-cba2-4a63-8c81-7a8a41c93f9c-2021-06-30T215754.231Z,2021-06-30T21:57:54.231Z,Leigh syndrome
IARS2,HGNC:29685,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50877212-c671-406b-8cb6-195c7369a96c-2019-11-25T154442.667Z,2019-11-25T15:44:42.667Z,Leigh syndrome
LIAS,HGNC:16429,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec6f6c96-262d-4ab8-ab7a-b09d585689ca-2021-03-11T171936.261Z,2021-03-11T17:19:36.261Z,Leigh syndrome
LIPT1,HGNC:29569,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55d66b81-fe31-4965-b5fc-483393af820d-2021-04-09T142912.496Z,2021-04-09T14:29:12.496Z,Leigh syndrome
LONP1,HGNC:9479,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3da0a308-3a7e-4101-b40b-1f23db106aea-2021-04-09T140215.539Z,2021-04-09T14:02:15.539Z,Leigh syndrome
LRPPRC,HGNC:15714,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79691365-1911-423c-ab14-73a1f509ed22-2019-12-19T190157.942Z,2019-12-19T19:01:57.942Z,Leigh syndrome
MECR,HGNC:19691,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_75fcef99-f3fe-43b3-a544-a91f04ed1285-2021-06-14T142534.349Z,2021-06-14T14:25:34.349Z,Leigh syndrome
MFF,HGNC:24858,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4484881f-277f-47a2-b1dd-70072ec941e0-2021-04-09T141836.756Z,2021-04-09T14:18:36.756Z,Leigh syndrome
MORC2,HGNC:23573,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_23358115-fe60-41c7-b01e-44d1cb8329b1-2021-06-14T142952.247Z,2021-06-14T14:29:52.247Z,Leigh syndrome
MRPS34,HGNC:16618,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41d20487-f150-41b6-947c-ce77e405e8de-2020-08-27T162259.700Z,2020-08-27T16:22:59.700Z,Leigh syndrome
MT-ATP6,HGNC:7414,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e492464b-cb98-4bf4-a12e-169b59576b04-2021-06-28T145350.161Z,2021-06-28T14:53:50.161Z,Leigh syndrome
MT-CO1,HGNC:7419,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_227922e2-1f4e-4bd5-9fc2-d48bac5d394f-2021-06-28T143540.269Z,2021-06-28T14:35:40.269Z,Leigh syndrome
MT-CO2,HGNC:7421,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41d6a25c-4300-4e43-b0f8-1923ff3ddad8-2021-06-28T144136.451Z,2021-06-28T14:41:36.451Z,Leigh syndrome
MT-CO3,HGNC:7422,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_996428ee-5af2-458b-afb7-6e29348c585a-2021-06-28T144716.059Z,2021-06-28T14:47:16.059Z,Leigh syndrome
MT-ND1,HGNC:7455,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8bb99c59-15c9-4e19-ba8b-df6cb800c32d-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Leigh syndrome
MT-ND2,HGNC:7456,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80f1dcc9-aaf3-45f7-987a-4e0d83140913-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Leigh syndrome
MT-ND4,HGNC:7459,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f05be3e5-352f-49a5-84af-8846d6839373-2021-05-17T040000.000Z,2021-05-17T04:00:00.000Z,Leigh syndrome
MT-ND5,HGNC:7461,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e941d385-716f-4264-8f24-ffe3022579e2-2021-06-14T155537.548Z,2021-06-14T15:55:37.548Z,Leigh syndrome
MT-ND6,HGNC:7462,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_836f975f-27f5-47c9-a58e-35089b6b39e6-2021-05-17T040000.000Z,2021-05-17T04:00:00.000Z,Leigh syndrome
MT-TI,HGNC:7488,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69991755-b62f-42aa-bbe3-30ac10e4311d-2021-02-03T050000.000Z,2021-02-03T05:00:00.000Z,Leigh syndrome
MT-TK,HGNC:7489,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f237644-83f5-412e-9bfa-01fbd280c15a-2021-06-28T155537.306Z,2021-06-28T15:55:37.306Z,Leigh syndrome
MT-TL1,HGNC:7490,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efef782a-88db-470d-9687-23629c75e05a-2021-06-28T154710.419Z,2021-06-28T15:47:10.419Z,Leigh syndrome
MT-TL2,HGNC:7491,Leigh syndrome,MONDO:0009723,MT,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8cee9c77-e47a-4b2f-8029-b1da28799df6-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Leigh syndrome
MT-TV,HGNC:7500,Leigh syndrome,MONDO:0009723,MT,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42f2fc91-c26d-416c-8d93-448e4a52983b-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Leigh syndrome
MT-TW,HGNC:7501,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3dc54202-27f3-4bf4-883f-5273a49dcb70-2021-06-28T150550.120Z,2021-06-28T15:05:50.120Z,Leigh syndrome
MTFMT,HGNC:29666,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e7a00ee-ef09-443f-9d66-03128e1fb225-2020-03-19T194517.723Z,2020-03-19T19:45:17.723Z,Leigh syndrome
MTRFR,HGNC:26784,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78f97463-d8b2-411a-9292-1908646dac77-2021-04-01T174500.572Z,2021-04-01T17:45:00.572Z,Leigh syndrome
NARS2,HGNC:26274,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8874861d-9d28-440d-a751-54c22df0d4ad-2019-12-19T190722.572Z,2019-12-19T19:07:22.572Z,Leigh syndrome
NAXE,HGNC:18453,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a062b287-a561-4c3e-942a-3379dee307c8-2021-04-09T142130.880Z,2021-04-09T14:21:30.880Z,Leigh syndrome
NDUFA1,HGNC:7683,Leigh syndrome,MONDO:0009723,XL,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_497170a6-a042-46cb-9809-3c3094fcd05e-2019-05-20T184847.372Z,2019-05-20T18:48:47.372Z,Leigh syndrome
NDUFA10,HGNC:7684,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e40eec3c-0ce0-442e-9058-6bf4d90d6dc3-2019-11-25T162049.949Z,2019-11-25T16:20:49.949Z,Leigh syndrome
NDUFA12,HGNC:23987,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81f38f43-5e0c-4cb8-9be8-091f2c8a2c71-2019-11-25T160815.348Z,2019-11-25T16:08:15.348Z,Leigh syndrome
NDUFA13,HGNC:17194,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0bc56951-c454-4e79-95f3-7ffda20482b7-2021-01-21T005411.435Z,2021-01-21T00:54:11.435Z,Leigh syndrome
NDUFA2,HGNC:7685,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f40eb04-1cc3-477c-ab0a-c8162958fd4f-2019-05-20T190623.871Z,2019-05-20T19:06:23.871Z,Leigh syndrome
NDUFA4,HGNC:7687,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2854d105-0d20-4a19-9dee-d7aa6a60ed99-2021-01-14T214439.481Z,2021-01-14T21:44:39.481Z,Leigh syndrome
NDUFA9,HGNC:7693,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87c6c5c5-7bf7-4bd2-94f0-2d529a512e74-2019-11-25T162851.567Z,2019-11-25T16:28:51.567Z,Leigh syndrome
NDUFAF2,HGNC:28086,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c26c06d-17dc-4783-8145-5de35c9a73f5-2020-11-23T193634.959Z,2020-11-23T19:36:34.959Z,Leigh syndrome
NDUFAF4,HGNC:21034,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2df4e73b-a8a5-4ce2-bab6-2be732d3c542-2020-02-12T194734.160Z,2020-02-12T19:47:34.160Z,Leigh syndrome
NDUFAF5,HGNC:15899,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55a2c102-f05d-4ff1-9527-3a55fb3f00c3-2021-04-09T135236.631Z,2021-04-09T13:52:36.631Z,Leigh syndrome
NDUFAF6,HGNC:28625,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f7b6ace1-5b89-41c7-83a6-d6f37826d8c5-2020-11-23T194212.660Z,2020-11-23T19:42:12.660Z,Leigh syndrome
NDUFAF8,HGNC:33551,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3459bec0-88a8-463b-a135-54670357137a-2021-04-01T195856.777Z,2021-04-01T19:58:56.777Z,Leigh syndrome
NDUFB8,HGNC:7703,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bef2c930-4b79-4938-8325-94a0f58cdfd9-2021-01-21T004458.566Z,2021-01-21T00:44:58.566Z,Leigh syndrome
NDUFC2,HGNC:7706,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d819bce-43ed-45a3-a16b-74033d432272-2021-01-21T004055.963Z,2021-01-21T00:40:55.963Z,Leigh syndrome
NDUFS1,HGNC:7707,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6995e66-f840-485a-a635-b64cb9f45cd9-2019-06-20T161718.750Z,2019-06-20T16:17:18.750Z,Leigh syndrome
NDUFS2,HGNC:7708,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6df726c1-2897-46f8-aed1-f9939b9acf0c-2021-04-09T143144.546Z,2021-04-09T14:31:44.546Z,Leigh syndrome
NDUFS3,HGNC:7710,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ae2af25-4fc1-48c3-a289-fae04977b192-2019-06-20T162502.779Z,2019-06-20T16:25:02.779Z,Leigh syndrome
NDUFS4,HGNC:7711,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ed6ae7f-8c64-4ca3-a71b-6e97ae21d71d-2019-04-08T162953.550Z,2019-04-08T16:29:53.550Z,Leigh syndrome
NDUFS7,HGNC:7714,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b702a150-de60-429e-bb12-ba8cde1483e7-2019-11-25T160008.570Z,2019-11-25T16:00:08.570Z,Leigh syndrome
NDUFS8,HGNC:7715,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01a27520-f92a-4b81-b63b-c15132c873be-2019-11-25T152406.734Z,2019-11-25T15:24:06.734Z,Leigh syndrome
NDUFV1,HGNC:7716,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b96e332-59c4-4636-8bdf-bf893ea059f1-2019-11-26T163430.120Z,2019-11-26T16:34:30.120Z,Leigh syndrome
NDUFV2,HGNC:7717,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1266aed1-8c25-4b28-bf8a-a0e16d9b3da9-2019-11-25T145748.766Z,2019-11-25T14:57:48.766Z,Leigh syndrome
NUBPL,HGNC:20278,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4365ffcd-637c-4862-9fa0-fb8a780a6d25-2020-03-19T195115.036Z,2020-03-19T19:51:15.036Z,Leigh syndrome
NUP62,HGNC:8066,Leigh syndrome,MONDO:0009723,AR,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8441b4db-da7d-49a2-816c-9f868a96ffab-2020-12-16T050000.000Z,2020-12-16T05:00:00.000Z,Leigh syndrome
OPA1,HGNC:8140,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e72abd1-4b0a-4f66-b681-7a51d4467026-2021-06-14T152117.821Z,2021-06-14T15:21:17.821Z,Leigh syndrome
PDHA1,HGNC:8806,Leigh syndrome,MONDO:0009723,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a579324c-3586-4636-9192-c2ea29391a4e-2019-04-08T161203.224Z,2019-04-08T16:12:03.224Z,Leigh syndrome
PDHB,HGNC:8808,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_133f688f-b498-4f5e-bd9b-b3406880ddd4-2021-03-11T172853.362Z,2021-03-11T17:28:53.362Z,Leigh syndrome
PDHX,HGNC:21350,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3608ac5e-4b1f-4bb5-aa0c-cc42a2262304-2021-03-11T174226.092Z,2021-03-11T17:42:26.092Z,Leigh syndrome
PDSS2,HGNC:23041,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0928f3-2b7d-4622-bc96-68a4d0078826-2021-03-11T172336.036Z,2021-03-11T17:23:36.036Z,Leigh syndrome
PET100,HGNC:40038,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33c546f5-a285-424b-9ae2-9ca4fc718c67-2019-05-20T191347.510Z,2019-05-20T19:13:47.510Z,Leigh syndrome
PET117,HGNC:40045,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69d9bbe0-ba3f-44f0-b340-d6d824cb969f-2019-05-20T191805.361Z,2019-05-20T19:18:05.361Z,Leigh syndrome
PNPT1,HGNC:23166,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ed99943-2ab9-417d-b0ec-ddbfa11c8645-2020-03-19T191429.965Z,2020-03-19T19:14:29.965Z,Leigh syndrome
POLG,HGNC:9179,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1212393e-b517-4430-a8d7-df7e32295aff-2021-06-30T144955.983Z,2021-06-30T14:49:55.983Z,Leigh syndrome
PTCD3,HGNC:24717,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac3d1e08-56f0-43b6-a2fa-0d06571ba121-2019-06-20T164419.242Z,2019-06-20T16:44:19.242Z,Leigh syndrome
RANBP2,HGNC:9848,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_183be314-face-471f-9643-9cc1a302636f-2021-06-30T145342.020Z,2021-06-30T14:53:42.020Z,Leigh syndrome
RNASEH1,HGNC:18466,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcf8b7a4-7bd5-45fe-824c-6a90825620f7-2021-01-14T213824.328Z,2021-01-14T21:38:24.328Z,Leigh syndrome
SCO2,HGNC:10604,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_011dd1c7-94bb-4a70-8b95-cc25432a5ea2-2019-03-28T154245.471Z,2019-03-28T15:42:45.471Z,Leigh syndrome
SDHA,HGNC:10680,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4c5801d0-5839-47d9-81cc-a53cea959b57-2019-05-20T190935.665Z,2019-05-20T19:09:35.665Z,Leigh syndrome
SDHAF1,HGNC:33867,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0baf56d2-40f8-465a-9b50-22f57481a5cb-2020-02-12T201133.569Z,2020-02-12T20:11:33.569Z,Leigh syndrome
SERAC1,HGNC:21061,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf6861ce-e13a-42c9-a4ff-942a83874bfd-2021-01-14T213356.750Z,2021-01-14T21:33:56.750Z,Leigh syndrome
SLC19A3,HGNC:16266,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3907183-4cb2-4df7-bace-ecc1821b3acc-2019-01-14T170000.000Z,2019-01-14T17:00:00.000Z,Leigh syndrome
SLC25A19,HGNC:14409,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ae17da7-86b0-4aba-a401-de1ccb6ecb83-2020-08-27T162850.918Z,2020-08-27T16:28:50.918Z,Leigh syndrome
SLC25A4,HGNC:10990,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a6890a4-e2d5-4895-956d-3f3103ec6a2b-2021-06-14T151738.675Z,2021-06-14T15:17:38.675Z,Leigh syndrome
SLC25A46,HGNC:25198,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e456b6d-7a9b-42d2-ab51-0531f5184b41-2020-08-27T163757.565Z,2020-08-27T16:37:57.565Z,Leigh syndrome
SLC39A8,HGNC:20862,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fddaae4-d982-49e7-9e83-b84d15f3cf2c-2020-11-23T195104.867Z,2020-11-23T19:51:04.867Z,Leigh syndrome
SQOR,HGNC:20390,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09ea3b0c-cc3a-44d1-a702-9f1674c33040-2021-01-21T005124.845Z,2021-01-21T00:51:24.845Z,Leigh syndrome
SSBP1,HGNC:11317,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ef6f4e7-6e59-4eaf-b303-7f975542d1b9-2021-06-14T144803.625Z,2021-06-14T14:48:03.625Z,Leigh syndrome
SUCLA2,HGNC:11448,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eedc8c99-a02a-4a34-ba72-1b0fc975e63f-2019-04-18T180100.762Z,2019-04-18T18:01:00.762Z,Leigh syndrome
SUCLG1,HGNC:11449,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd0a5a96-69b8-47fb-9b7b-17de29439ecc-2019-04-18T181448.882Z,2019-04-18T18:14:48.882Z,Leigh syndrome
SURF1,HGNC:11474,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ed17d9b-e746-4f1f-9c39-26f46bb2eadc-2019-04-08T160338.698Z,2019-04-08T16:03:38.698Z,Leigh syndrome
TACO1,HGNC:24316,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae2fd0e4-db4e-4e17-bfc8-c43719066f97-2019-10-16T150433.004Z,2019-10-16T15:04:33.004Z,Leigh syndrome
TARS2,HGNC:30740,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_475a994f-8420-45bb-8f14-9fe85cdcdbbc-2021-06-14T144425.888Z,2021-06-14T14:44:25.888Z,Leigh syndrome
TIMMDC1,HGNC:1321,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83d26d62-2863-46d9-ad7d-96c086e65e8e-2021-06-30T220013.257Z,2021-06-30T22:00:13.257Z,Leigh syndrome
TPK1,HGNC:17358,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74e89426-cb27-4474-b892-dc303a9de644-2021-01-14T212800.773Z,2021-01-14T21:28:00.773Z,Leigh syndrome
TRMU,HGNC:25481,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1d9d958-be13-4018-ab9c-305788171d1e-2021-01-21T004755.799Z,2021-01-21T00:47:55.799Z,Leigh syndrome
TSFM,HGNC:12367,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3d30a3f-a054-4812-9b97-116a8834fcb1-2020-02-12T195529.785Z,2020-02-12T19:55:29.785Z,Leigh syndrome
TTC19,HGNC:26006,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8dc9dcb6-1f63-41b1-80f1-a0f2a87b5ec4-2019-09-19T160132.570Z,2019-09-19T16:01:32.570Z,Leigh syndrome
UQCRQ,HGNC:29594,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7-2019-10-16T144656.909Z,2019-10-16T14:46:56.909Z,Leigh syndrome
VPS13D,HGNC:23595,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f179add-fcdb-4ea0-bc3c-506f825d2dac-2021-06-14T143234.435Z,2021-06-14T14:32:34.435Z,Leigh syndrome
GBA,HGNC:4177,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9201c03f-10de-447c-9b84-194f14b549b6-2022-05-03T134810.206Z,2022-05-03T13:48:10.206Z,Parkinson's disease
LRRK2,HGNC:18618,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2728e13a-b95a-4c55-8cba-082260094ecd-2021-05-03T160000.000Z,2021-05-03T16:00:00.000Z,Parkinson's disease
PARK7,HGNC:16369,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d79439d2-844b-4ba6-aceb-e6b179eaaa01-2022-06-27T160000.000Z,2022-06-27T16:00:00.000Z,Parkinson's disease
PINK1,HGNC:14581,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1999e6c4-eb15-438a-a4ea-98989112dcbb-2023-01-18T190000.000Z,2023-01-18T19:00:00.000Z,Parkinson's disease
PRKN,HGNC:8607,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b39c4a0-f6bd-4afc-b2a7-f234eab5a667-2023-01-18T190000.000Z,2023-01-18T19:00:00.000Z,Parkinson's disease
SNCA,HGNC:11138,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d21593ae-ed10-4442-8167-24f96f917302-2022-05-03T134931.425Z,2022-05-03T13:49:31.425Z,Parkinson's disease
VPS35,HGNC:13487,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0e546d6-8a44-4e9d-83aa-f781ec4ec166-2021-11-03T134517.796Z,2021-11-03T13:45:17.796Z,Parkinson's disease
CDKL5,HGNC:11411,CDKL5 disorder,MONDO:0100039,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a80cd86d-b085-4f35-9379-12a53ef367e2-2018-07-02T145731.072Z,2018-07-02T14:57:31.072Z,Rett and Angelman-like Disorders
FOXG1,HGNC:3811,FOXG1 disorder,MONDO:0100040,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f14c6c5-b051-4c94-b9c6-3b80771eed22-2018-07-02T140827.839Z,2018-07-02T14:08:27.839Z,Rett and Angelman-like Disorders
MECP2,HGNC:6990,Rett syndrome,MONDO:0010726,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2df006ff-5ab4-4926-9b72-48909b09e608-2018-05-02T132629.570Z,2018-05-02T13:26:29.570Z,Rett and Angelman-like Disorders
SLC9A6,HGNC:11079,Christianson syndrome,MONDO:0010278,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d97fc8d-e744-449a-939c-386895c121cd-2018-05-02T160000.000Z,2018-05-02T16:00:00.000Z,Rett and Angelman-like Disorders
TCF4,HGNC:11634,Pitt-Hopkins syndrome,MONDO:0012589,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_096f830c-0065-456a-9e26-db54fd157981-2018-05-02T170000.000Z,2018-05-02T17:00:00.000Z,Rett and Angelman-like Disorders
UBE3A,HGNC:12496,Angelman syndrome,MONDO:0007113,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df25de82-ea9a-4d86-8b42-6587a39650e3-2018-05-02T132344.716Z,2018-05-02T13:23:44.716Z,Rett and Angelman-like Disorders
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
